Stimuli-responsive nanomaterials for controlled delivery by light, magnetic and electrical triggers by Zhang, Meng Bi
 
 
 
 
 
STIMULI-RESPONSIVE NANOMATERIALS FOR 
CONTROLLED DELIVERY BY LIGHT, MAGNETIC 
AND ELECTRICAL TRIGGERS 
 
 
 
 
 
Meng Bi Zhang 
 
December 2017 
 
 
 
 
 
 
 
 
 
A thesis submitted for the degree of Doctor of Philosophy of 
The Australian National University 
 
 
 
© Copyright by Meng Bi Zhang 2017 
All Rights Reserved 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
Declaration  
 
I certify that this thesis does not include any material that has previously been submitted 
for a degree in any university. To the best of my knowledge, it does not contain any 
material previously published or written by another person except where due and clear 
reference is made in the text. The work in this thesis is my own, except for the 
contributions made by others as described in the Acknowledgements.  
 
 
 
 
 
Meng Bi Zhang 
 
12th of December, 2017 
 
 
 
 
 
 
 
 
 
 
Word Count: 42,295 
 
 
 
  
 
 
  
This work is dedicated to the wonderful teachers I have had over the years, 
from Mrs. H through to Prof. L, and with special mention to my mother for 
being the first.    
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgements 
 
This accomplishment does not belong to me alone. I owe much and more to the 
following fine folk.  
First and foremost, I thank the many wiser minds who aided me along the 
way. The road was often long and winding, and some days it seemed to go uphill on 
both sides. In particular, Dr Antonio Tricoli, thank you for giving me the freedom 
and support to pursue my many ideas, even the mad ones. Especially the mad ones. 
In the end, we did some fascinating science together.  
Secondly, I thank the many collaborators who made this work possible. It 
was a privilege to have worked with you. Special thanks must go to the many 
technicians who helped along the way. Many of the most interesting results presented 
here would have been impossible without your time, expertise and patience.  
Thirdly, I thank my immediate colleagues in the Nanotechnology Research 
Group. Your company made the good times much more enjoyable and the bad times 
almost tolerable. Special mention goes to Noushin Nasiri who was there since the 
beginning. We battled many dragons together.  
I would like to acknowledge the Australian government for giving me food to 
eat and a roof to sleep under for the duration. Without such funding, the work may 
indeed have happened, but I would surely be poorer, colder, thinner, and sadder.  
To my friends good and true, thank you for keeping me sane with tea, cake, 
crafts and laughs. You know who you are.  
And finally, to the ones who supported me from coast-to-coast, thank you for 
your patience in the whole affair. As the days weathered in weeks and months and 
years, your resolve remained strong even as my own began to crumble, and that 
made all the difference in the end. Your love stretched wider and warmer than the 
desert between us, and I am grateful every day for it.  
 
“So long and thanks for the fish.” 
 
 
  
 
 
Abstract 
 
The use of nanomaterials for biomedical applications is an emerging and important 
field. This is particularly true of advancements in targeted and controlled drug 
delivery, which offer several important improvements over traditional drug 
administration. The clinical efficacy of small-molecule therapeutics is currently 
limited by many factors, including: poor solubility, inefficient cellular uptake, overly 
rapid renal clearance and an inability to target only desired locations such as diseased 
tissues. The use of nanocarriers for drug delivery may greatly improve the efficacy 
over traditional therapeutics by lowering the total dosage, limiting the exposure to 
affected areas only, and giving greater temporal control over drug elution. These 
materials often make use of both organic and inorganic components, exploiting the 
unique and useful properties of each constituent to achieve novel, synergistic 
functions. 
This dissertation presents a study of nanocomposites comprising the three 
most important materials in this field: titania, iron oxides and polypyrrole. Titania is 
a strong photocatalyst, iron oxides provide useful responses to applied magnetic 
fields, and polypyrrole is a polymer with unique electrochemical properties. Studies 
in this dissertation were aimed at combining these three materials to create a novel 
structure that is responsive towards light, magnetic fields and electrical stimulation to 
serve as an enabling platform for the loading and release of biologically interesting 
compounds.  
These nanomaterials have been paired with amino acids L-lysine and L-
glutamic acid, two organic molecules of interest due to their ability to bind to DNA 
and proteins, and to form prodrugs that exhibit enhanced performance compared to 
 
 
traditionally administered medicines. Two model compounds have been loaded and 
released on these carriers: Ketoprofen, an important anti-inflammatory that is 
traditionally hindered by its limited cellular uptake levels; and fluorescein 
isothiocyanate, a fluorescent dye molecule that is a common tool used in this field for 
nanocarrier location and easy visualisation of release-related kinetics.  
First, an investigation into the effect of pH on the binding of amino acids to 
titania, iron oxide and polypyrrole is presented with a view towards optimising the 
functionalised material for subsequent loading and release of the model drugs (in this 
case, amine-reactive molecules). The release mechanism of photo-activated TiO2 is 
studied in detail with a particular focus on the competition between the cleavage of 
bonds versus organic degradation on the catalyst’s surface. Both mechanisms are 
currently reported in literature and studies were aimed at identifying the more 
dominant pathway in the system developed alongside understanding the crucial role 
of reaction time scales on this photochemistry.  
Then, the pH-tuneable flocculation of the amino acid-functionalised 
nanoparticles via electrostatic attractions is exploited to create a novel, anisotropic 
assembly of iron oxides. These filaments display a dynamic and unique response 
towards a rotating magnetic field by creating local microscale vortices. This motion 
is used to enhance local delivery rate of molecules through magnetic-field triggered 
microscale mixing.  
Finally, this anisotropic iron oxide structure is combined with polypyrrole to 
create a unique, novel material that possesses directional conductivity, a 
photothermal response, and magnetic field-triggered release of loaded molecules at 
enhanced and controllable rates compared with traditional diffusion-limited systems.  
 
 
 
 Thesis Organisation 
A detailed review of literature is given in Chapter 1 Background and Literature 
Review. This comprises an introduction to metal oxide nanomaterials and their role 
in nanomedicine (Section 1.2), magnetic nanomaterials and their unique magnetic 
field responsive character (Section 1.3), synthesis of metal oxide nanomaterials 
(Section 1.4), functionalisation strategies (Section 1.5), intrinsically conductive 
polymers (Section 1.6), and biocompatibility (Section 1.7). The key research 
questions arising from this literature review and associated research aims are 
presented in Section 1.8. The results of experiments on the effect of pH on amino 
acid functionalisation of TiO2 and Fe3O4 will be presented in Chapter 2. Chapter 3 
investigates the flocculation effect of this functionalised material and presents a 
method to exploit this for self-assembly of Fe3O4 under a magnetic field to create 
novel, anisotropic structures. An analogous functionalisation of PPy with amino 
acids is presented in Chapter 4. Finally, the findings of previous chapters are 
combined to produce a composite material of amino acid-functionalised, light-
responsive, conductive and magnetically responsive material that is presented in 
Chapter 5. Conclusions and recommendations for future work will be presented in 
Chapter 6. Methods and materials are given at the end of each chapter where 
appropriate. References will follow at the end of the document.  
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CHAPTER ONE 
Background and Literature Review
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Chapter One – Background and Literature Review 
1.1 Overview Literature R 
The application of nanomaterials for biomedical applications is a field that has been 
gaining increasing importance in the past decade. This scientific discipline involves the 
design, synthesis and application of precisely engineering structures in the nano-to-
microscale for novel therapeutic and diagnostic functions. This enabling technology 
makes use of both organic and inorganic components, exploiting the unique and useful 
properties of each constituent to novel, synergistic functions.  
In particular, the development of such nanomaterials that are designed to undergo 
predetermined responses towards anticipated or applied stimuli has gained increasing 
importance in medicine. Such structures make use of endogenous or exogenous stimuli 
(or combination thereof) and translate these triggers into desirable and useful actions of 
some medical benefit.  
Endogenous stimuli (that is, a stimulus that originates from the body itself) that 
are currently known include pH[1] and temperature[2] changes, or response towards 
particular enzymes[3]. Endogenous stimulation has the advantage of being naturally 
occurring, meaning no addition technology is required and there is therefore no 
additional health risk arising from the application of the stimulus. Additionally, changes 
in local pH, temperature and enzymes are often signals of important changes in 
biological function that may be a direct symptom of disease and is an indicator that the 
intervention offered by the nanomaterial is required.  
On the other hand, exogenous (externally applied) stimuli are currently popular 
due to the greater degree of control and predictability that is afforded by such systems. 
Popular exogenous stimuli include light, magnetic field and ultrasound[4] (Figure 1). 
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These methods differ on several terms, including depth of penetration within human 
tissues, cost of operation, and potential side effects.  
The nanocarrier is typically designed to undergo useful responses to stimulation 
by undergoing physical changes such as by swelling or shrinking[5] and opening or 
closing[6], or chemical changes such as by oxidising or reducing[7]. These responses may 
be used for applications such as drug release[8], photo[9] /chemo[10]/magnetotherapies[11] 
and directed cell growth[12].  
The potential of such materials towards drug delivery is particularly significant. 
The clinical efficacy of traditionally administered medicine is currently limited by many 
factors, including: poor solubility[13], inefficient cellular uptake[14], and an inability to 
target only at the desired location of diseased tissues[15]. The use of nanocarriers for 
drug delivery may greatly improve the efficacy of treatment by addressing these issues. 
Tethering a pharmaceutical to a nanomaterial that can be directed to an affected site 
such as a tumour using, for example, a magnetic field, and then being able to control the 
release time and rate of the drug for maximum efficiency would represent a significant 
advancement.  
 
 
Figure 1. Overview of different endogenous and exogenous stimuli for stimulation of nanomaterials. 
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Over the past decade, the field has exploded with solutions of ever-increasing 
sophistication to achieve these aims. Here, a survey of relevant literature has been 
provided with a focus towards the following:  
• Material type: Metals, ceramics, polymers and various composites of all 
three material classes have been proposed for these applications. This thesis 
will focus primarily on ceramics and polymers.  
• Synthesis strategies: The most prominent strategies for the synthesis of the 
above materials are outlined with a particular emphasis on flame-spray 
pyrolysis, a high-throughput solution for production of ceramic 
nanoparticles.  
• Functionalisation strategies: The key methods for modifying the 
nanomaterial surfaces with functional organic molecules will be studied. The 
importance of amino acids in this role and the challenges of using them are 
discussed.   
• Biocompatibility issues: Finally, a literature survey is conducted to ascertain 
the biocompatibility of the materials used in this thesis.  
1.2 Ceramic Nanomaterials for Drug Release  
Ceramic nanomaterials, particularly nanostructured metal oxides, have emerged as 
an important class of materials for bio-applications due to several key desirable 
properties. The most prominent and important ceramic nanomaterials are titanium 
dioxide (TiO2), silicon dioxide (SiO2) and iron oxides (FexOy). TiO2, particularly in the 
Anatase phase, is a strong photocatalyst that has been used for light-triggered drug 
release[16]. SiO2 is commonly used as an inert coating or carrier for functional 
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moieties[17]. Magnetic phases of iron oxides, such as magnetite (Fe3O4), maghemite (γ-
Fe2O3) and hematite (α-Fe2O3) provide useful magnetic functionality while being 
inherently less toxic than other magnetic materials that contain heavy metal species (e.g. 
Co, Ni)[18]. The following section will discuss in detail the state-of-the-art in terms of 
the design, synthesis and application of TiO2 and SiO2. Due to the prominence of iron 
oxides, they are discussed separately in Section 1.2 Magnetic Nanomaterials.  
 
1.2.1 Titanium dioxide the photocatalyst 
Titanium dioxide is of key interest in applications such as controlled drug delivery as it 
is one of the strongest photocatalysts that is currently known. The photocatalytic 
behaviour of TiO2 is reasonably well-understood. Upon illumination with ultraviolet 
light corresponding to the bandgap of TiO2, ca. 3.05eV  for anatase and 2.98eV for 
rutile,[19] an electron is excited from the valence band to the conductance band, 
generating charge carriers (electron and hole). The photogenerated holes react with 
water to create hydroxyl radicals and together begin to oxidise the nearby organic 
molecules at the particle surface (Figure 2). At the same time, electrons in the 
conduction band will be involved in reduction reactions with dissolved oxygen to 
generate peroxide.[20] This a property that has been exploited in other disciplines to great 
effect (e.g. solar cells, water splitting, self-cleaning coatings) and has recently been 
exploited in the context of drug delivery systems.[21]  
𝐻𝐻2𝑂𝑂 +  ℎ+ → 𝑂𝑂𝐻𝐻 ∙  +𝐻𝐻+                                 (Equation 1) 
𝑂𝑂2 +  2𝑒𝑒− + 2𝐻𝐻+ → 𝐻𝐻2𝑂𝑂2                                (Equation 2) 
Designs that use TiO2 for drug delivery typically involve first the adsorption of 
functional molecules onto the TiO2 surface (either a drug directly or via a linking 
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molecule), then release of this bound molecule is triggered by exploiting the 
photocatalytic redox events at the nanoparticle surface[22]. The mechanism behind this is 
not yet entirely understood. For example, although it has been widely observed that 
whole, undamaged organic molecules such as pharmaceuticals[23] may be delivered by 
this method, there have been studies suggesting that adsorbed molecules, e.g. oxalic 
acid, are likely to be photocatalytically decomposed when TiO2 is exposed to light[24]. 
At the same time, other authors hypothesise that the redox events prefer to cleave the 
TiO2-organic ligand bond first and there is therefore little decomposition recorded at 
shorter time frames such as is typically required for drug release.[25]     
 
Figure 2. (a) Bandgaps of rutile, anatase and brookite.[19]. (b) General scheme for photocatalytic reactions 
at TiO2 nanoparticle surface in aqueous conditions. (c) Detailed hole-attack pathways for anatase and 
rutile. [26] 
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This area has been heavily researched in the past decade and remains an important topic 
today. A summary of key results to date have been presented in Table 1. The literature 
has been reviewed with respect to the following criteria:  
(i) Nanostructure 
Currently known TiO2 nanostructures include simple nanoparticle[27], porous 
nanoparticle[28], nanotube[29], and porous film[30]. Porous structures, particularly 
mesoporous structures have the advantage of high surface area that can be used for the 
binding of the target drugs[31]. However, simple nanoparticles have the advantage of 
smaller size and therefore ease of injection/ diffusion at the desired sites[32]. Porous 
films are suitable for implants designed for longer term application.  
(ii) Drug loaded/ delivered 
An attempt has been made to catalogue the range of currently known drugs that can be 
delivered using the photocatalytic response of TiO2. However, it should be noted that 
the identity of the delivered molecule is arguably one of the less important parameters. 
Given a good understanding of the mechanism behind attachment and release 
mechanism, it is possible to engineer the material to deliver any molecule of interest. 
(iii) Functional molecule (if present) 
Studies differ in the strategy used for loading the target drug onto the TiO2. Some 
adsorb the target molecule directly onto the metal oxide surface[33], while others use a 
linking functional molecule[34]. The use of a tethering molecule may result in a more 
robust binding of the drug, reducing unintended passive leaching of the drug out of the 
nanoparticle. However, this also introduces an additional complexity to the structure. 
For example, upon UV illumination, bonds may break between the TiO2 surface and the 
linking molecule and/or between the linking molecule and the target drug. Furthermore, 
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many drug molecules are highly specific and cannot be modified by a linker without 
losing efficacy, with the exception of modifications that result in easily metabolised 
prodrugs such as lysine-modified Ketoprofen, a transformation that in this case 
increases the effectiveness of the anti-inflammatory in question[35].  
(iv) Excitation wavelength 
The excitation wavelength is significant as UV light has high attenuation within 
tissue[36]. This means the penetration depth is typically low and damage to the 
surrounding tissue may be expected as the light energy dissipates. Light at longer 
wavelengths / lower energy is preferable in this respect.  
(v) Illumination time 
Similarly, the time scale over which the drug release happens is important both in terms 
of limiting the damage to healthy tissues[37] and determining the time required for 
effective elution of the drug away from the nanocarrier. For these reasons, it is desirable 
to minimise the time required for the release, or to consider pulsed release profiles.  
(vi) Drug loading content 
The final payload content as calculated as a weight ratio to the nanoparticle carrier is an 
important parameter as it serves as an efficiency metric for the drug delivery system. 
Due to the unknown toxicity of nanoparticles in general (in part due to their novelty and 
therefore lack of long-term studies), it is important to maximise this parameter.  
A survey of literature has been presented below (Table 1) on the use of TiO2 for 
release of drugs. There are two points of interest in the research to date. Firstly, it 
should be noted that, despite the photocatalytic character of TiO2, the majority of papers 
found did not make use of this directly. Instead, porous forms of TiO2 (commonly the 
nanotubes formed by anodic oxidation of Ti metal) were used as a passive base for the 
8 
 
Chapter One – Background and Literature Review 
loading and diffusion-limited release of the loaded drug out of the pore spaces. In such 
cases, the photocatalytic character of the TiO2 carrier has no bearing on the 
effectiveness of the platform, and a similar effect can be expected for any base material 
of similar surface area and porosity. As I will discuss in Section 1.2.3, this is the basis 
behind the popular use of mesoporous SiO2.  In these porous structures based on passive 
release, the time-frame for delivery of the payload molecule is usually in the range of 
several hours[38], and even up to the month scale[39] for full elution. On the other hand, 
photocatalysis is fast-acting. It should be noted that Shrestha et al. were able to achieve 
a remarkable release “within a few seconds” due to their use of a Siloxane linker that 
bound covalently to the TiO2 surface and then cleaved by the action of UV light 
illumination.[21] However, Shrestha et al.’s work is in the minority here, and highlights 
an opportunity for further studies of a photocatalytic-driven drug release system.  
Perhaps part of the hesitation in the use of light-activated release systems based 
on TiO2 is due to the inherent limitation of using UV in a biomedical context. The 
excitation wavelengths required to excite TiO2 are usually in the ultraviolet B (UV-B) 
region, the band gap of pure Anatase and Rutile being ca. 3.2 eV (387 nm) and 3.0 eV 
(413 nm) respectively[40]. Ultraviolet light is cytotoxic, causing inflammatory and 
immunosuppressant effects even after short-term exposure[41]. Furthermore, it attenuates 
quickly within tissues with low penetration past the epidermis[36] and is therefore 
unsuitable for triggering any internal devices. This is undesirable and must be improved 
if TiO2-based structures are to have a future in drug release. Strategies have emerged to 
improve this property. For example, X-rays may also be used to excite photochemical 
reactions at the TiO2 surface to trigger photocatalytic drug release.[42, 43] Although X-
rays carry the inherent risk of high energy ionising radiation, this may be justified by 
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the benefits of targeted drug delivery and partially mitigated by the short exposure times 
typically required for photocatalysis to occur in a similar risk management strategy to 
the current use of X-rays for diagnosis. 
Alternatively, the band gap of TiO2 may be shifted towards the lower energy / 
longer wavelength side of the electromagnetism spectrum by applying some suitable 
modifications. Visible light presents the advantage of being less toxic than ultraviolet[44] 
and penetrates more deeply in human tissues than ultraviolet. However, near-infrared 
light is superior in this regard, having the best penetration in tissue[45] when compared 
with both visible[46] and ultraviolet[36]. It is for this reason that NIR-triggered 
nanomaterials (usually coupled with a thermoresponsive component) have become an 
important area of research.  
For example, doping titanium oxides with metal ions such as Ru[47], V[48] and 
Fe[49] or non-metals such as C[50], N[51], S[52] and B[53] may shift the wavelength into the 
visible range[54] and even leading into the NIR[55] range. Alternatively, a sensitising dye 
may be coupled with TiO2 nanoparticles to extend the wavelength into the visible range 
(typically < 750 nm). This strategy is widely used for improving the absorption of 
natural light in dye-sensitised solar cells[56] and water-splitting[57]. The most prominent 
dyes for this purpose Rhodamine B[58], Coumarin[59] and Ruthenium complexes[60] are 
all well-known for their toxicity, a disadvantage that cannot easily be overcome. 
Finally, TiO2 nanoparticles may be coupled with plasmonic Au[61] and Ag[62] 
nanoparticles. Plasmonic Au in particular is a popular choice for drug delivery due to 
the tuneable excitation wavelength and the chemically and biologically inert nature of 
gold[63].  
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Despite these limitations, TiO2 remains a popular study subject in drug release. 
However, perhaps it should be noted that TiO2 is better suited for application in external 
applications such as wound dressings, and that while its optical properties can be 
improved, it is worthwhile considering that other materials may be better candidates for 
internal applications. 
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Table 1 Selected results on TiO2 for light-activated release of drugs 
TiO2 structure Drug Delivered  Linking Molecule Excitation 
wavelength 
Release time Loading 
Content 
Source 
Nanotube Horseradish 
peroxidase 
 APTES 325 0 – 600s ∼4.4 × 10−11 
nmol per tube 
[31] 
TiO2  core-shell 
composites 
Doxorubicin  None 980 nm 0 – 50 hours N/A [64] 
Nanoporous film Dexamethasone  None None 0 – 48 hour 362 ng/ mm2 [65] 
Nanotube Paclitaxel, BSA  None  0 – 50 days Paclitaxel: 
5μg/cm2. BSA: 
110μg/cm2 
[66] 
Nanotube Anti-microbial 
Peptides 
 None None 4h – 7 days N/A [67] 
Nanoporous 
particle 
Ibuprofen  None None 0 – 3000 mins N/A\ [33] 
Nanotubes Fluorescent Dye  Siloxane UV “A few seconds” N/A [21] 
Nanotubes Lysozyme, BSA  None None 0 – 110 min N/A [68] 
Nanoparticles Daunorubicin  None None 0 – 48 hours N/A [38] 
Nanoparticle Doxorubicin  N-
(Trimethoxysilylpropyl) 
ethylene diamine 
triacetic acid 
None 48 hour 9.2 wt% DOX 
to particle 
[34] 
Nanotubes indomethacin  PLGA coating None Up to 30 days N/A [39] 
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1.2.2 SiO2 the inert carrier 
Although nanoporous TiO2 structures have been used for drug loading and release, it is 
SiO2 that is more popular in this role. The almost ubiquitous popularity of SiO2 arises 
from its relative chemical inertia, a property that makes it an ideal passive carrier with 
long-term stability and low impact on its biological environment.  
In addition to the spherical particles, a mesoporous form of amorphous SiO2 has 
been known since the 1970s[69]. Mesoporous SiO2 nanoparticles have extremely high 
surface area (> 900 m2/g) is particularly useful for drug release[70] and gene 
transfection.[71] In the simplest designs, the porous SiO2 acts as a sponge whose many 
nanoscale pores may be loaded with the medical cargo, typically at levels exceeding 
those of other common drug delivery carriers such as liposomes, non-porous 
nanoparticles, or polymers.[17] The surface chemistry of SiO2 allows for electrostatic[72], 
hydrogen-bonding[73] and van der Waals interaction with the cargo, ultimately allowing 
for loading capacities that surpass the solubility limit of a solution or osmotic gradient 
loading. This is particularly effective for drugs that have low solubility in aqueous 
media but may form stable complexes with the nanoparticles, for example ibuprofen[74], 
itraconozole[74], and highly hydrophobic anti-cancer drug Tamoxifen[72]. 
In this simplest scenario, drug elution is ongoing out of the pores with a rate that 
is typically diffusion limited[75]. Modifications such as a polymer coating and gating 
molecules at the silica surface allow greater control over the delivery. For example, 
such components may be sensitive to endogenous triggers for the release of the payload. 
This includes local pH[76] and salt concentration.[77] With appropriate design, porous 
silica based nanocarriers may also be selectively activated by exogenous triggers. One 
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example is the use of labile, heat-sensitive gates[78]. Many strategies have been 
developed to functionalise SiO2 surfaces with organic molecules suitable as tethering 
ligands or gate-keeping molecules, just as for TiO2. These will be discussed in in 
Section 1.5.  
 
Figure 3. Example of Mesoporous SiO2 electron micrographs. [79] 
 
In addition to mesoporous particles, SiO2 is currently important as a coating or 
matrix material for other functional nanoparticles. For example, it is commonly used for 
coating superparamagnetic iron oxides (SPIONs)[80], quantum dots[81], and plasmonic 
Ag[82] and Au[83]. The chemical stability of SiO2 makes it an excellent barrier that can 
improve the cytotoxicity[84] and long-term stability of the functional nanoparticle cores 
while being simultaneously optically[85] and magnetically transparent so that it does not 
effect the functionality of the nanoparticle core. Finally, it is has a well-established 
Stöber synthesis route[86] that results in particles of well-controlled monodisperse 
morphology[87] at a large scale and low-cost, which has contributed in no small way to 
its currently ubiquitous popularity.   
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1.3 Magnetic nanomaterials for drug release 
Of the inorganic nanomaterials, none have attracted more interest for biomedical 
applications than magnetic materials. This is due to the importance of magnetism in 
biomedical applications that allow for ‘at-a-distance’ manipulation by the application of 
external magnetic fields[88]. Magnetic forces, unlike other stimuli such as light and x-
rays, have the advantage of deep penetration with relatively low attenuation or harm to 
living tissues[89]. This can be used to direct their location within biological systems[90], 
allowing for targeted therapies[91]. Secondly, magnetic nanoparticles may be used as 
MRI contrast enhancement agents[92], which allows easy monitoring of their location 
and action using existing technology[93], unlike other materials that effectively become 
invisible once they enter the biological system. A dynamic magnetic field may be also 
to induce magnetothermal responses[94] in the nanoparticles that can then be used for 
direct hyperthermia therapy[95] or for thermal-responsive drug delivery[94].   
Unsurprisingly, this class of materials has been extensively studied over the past 
decade. This is particularly true for iron oxides such as magnetite (Fe3O4) and hematite 
(α-Fe2O3), due to their biocompatibility over other magnetic materials[96]. As a result of 
research efforts to date, the ability to control their chemical and physical properties is 
already advanced. Various synthesis methods have been documented, and the ability to 
control their size, composition, shape and surface chemistries are well understood.  
Here, I have presented a survey of the key findings of the past two decades 
concerning the most biomedically important magnetic nanoparticles, their synthesis and 
resulting structures, methods for their functionalisation towards drug delivery, and 
finally some recent results in magnetic-field assisted synthesis.  
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1.3.1 Ferromagnetic versus superparamagnetic 
It is useful to categorise magnetic nanomaterials into ferromagnetic and 
superparamagnetic as these classes have distinct behaviours. While the development of 
nanoscale ferromagnetic structures is known[97, 98], there has been far more work 
devoted to superparamagnetic nanoparticles. This is due to the challenge of 
guaranteeing good dispersion of the ferromagnetic nanoparticles compared with 
superparamagnetic materials. Due to the high surface area of nanomaterials, they 
usually exhibit strong attraction due to the van der Waals[99] and electrostatic[100] 
interactions that cause the formation of large, flocculated assemblies. In the case of 
ferromagnetic materials, an additional flocculation pathway by attraction of permanent 
magnetic poles exists and may not be easily reversed.[101] The formation of such 
aggregates is a disadvantage as it undermines the desirable small size and 
correspondingly large surface area nanomaterials. The overall smalls size is critical as it 
allows for injection into the blood stream[102], penetration through the blood-brain-
barrier (BBB)[103], and uptake by cells[104]. The high surface area is crucial as it provides 
the platform for interaction with the system, such as through drug loading and 
release[105]. The formation of agglomerates in vivo may cause adverse effects such as 
thrombosis, although the critical size scale for this condition remains in debate[106].  
On the other hand, superparamagnetic materials only develop a magnetic 
moment when in the presence of an external, inducing magnetic field. Materials that are 
ordinarily ferromagnetic in the bulk may take on superparamagnetic properties as the 
particle size decreases below that of the domain size, meaning that they become single 
rather than multiple domain[107, 108]. This is one of the key examples where material 
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properties do not directly scale down to the nano regime. Materials with documented 
size-dependant superparamagnetism include cobalt ferrite[109] and magnetite (Fe3O4).[108] 
1.3.2 Magnetite 
A brief review of the literature shows that of the magnetic nanomaterials, 
superparamagnetic forms of magnetite, Fe3O4, are overwhelmingly preferred for 
biomedical applications. This may be in part due to its convenient and well-established 
superparamagnetic character, so important for applications of drug release. At particle 
diameters of 10 – 20 nm, Fe3O4 becomes superparamagnetic in nature[110], existing in 
single magnetic domains. This size scale of magnetite has been well-studied, and 
numerous efficient, facile, scalable routes of synthesis exist for producing such particles 
with highly specific size and shape control. Above this size Fe3O4 NPs will consist of 
multiple domains and show an open hysteresis value typical of ferromagnetic materials. 
Despite this, research towards biomedical applications of Fe3O4 has been conducted on 
a range of iron oxide sizes from 10 – 100 nm. Some key results of the past decade on 
superparamagnetic iron oxide nanoparticles (SPIONs) for biomedical purposes, their 
mode of synthesis, and their relevant material characteristics have been presented in the 
following table (Table. 2).  
1.3.3 Passive Versus Activated Release 
It is noteworthy that most drug release studies to date make use of a passive and 
sustained release mechanism wherein the payload is allowed to diffuse out gradually 
from the magnetically guided nanocarrier. However, in recent years, rapid rate drug 
release promoted by an active agent has gained much attention. An activated system 
allows for a local and temporary enhancement in release rate. This ‘on-off’ action 
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allows for pulsatile release profiles that is allows, additional control over therapy 
compared to a sustained, passive system.  
Release rate may be accelerated depending on the pH of the transfer medium 
and the relative solubility of the drug at these conditions.[111] The magnetothermal 
properties of SPIONs[112] have been well-studied and its use in hyperthermia therapy 
using the heat generated by magnetically vibrating SPIONs to directly destroy cancer 
cells[113] and bacteria has been proposed. However, this has not translated to a 
significant body of work on using a high frequency magnetic field (HFMF) to remotely 
trigger the release of drugs. An exception is the work of  Hu et al.[114] who present a 
drug-loaded SiO2 core surrounded by a Fe3O4 coating layer that is designed to rupture 
upon applying HFMF.[115] Meanwhile, Satakar et al.’s study makes use of the 
magnetothermal response combined with a thermally-responsive hydrogel coating.[116] 
Work on thermally-responsive hydrogel coatings for drug delivery are relatively well-
established[117], but as yet combining this with the magnetothermal effect has not been 
reported.   
It is possible to envision a system that combines magnetically activated delivery 
with MRI visibility to create a synergistic system. It is particularly popular in current 
research to functionalize the surface of magnetite and magnetite-composite materials 
with a targeting moiety for cancer-specificity towards the development of so-called 
‘theranostic’ systems that simultaneously allow visualisation of the affected areas and 
therapy through either drug or direct hyperthermia treatment.  
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Table 2. Magnetite-containing nanomaterials for biomedical purposes 
Size (nm) Shape Application Functional coatings Activation Targeting Source 
21 Sphere Drug Delivery 
(DOX) 
Polymer Passive  [118] 
10 Sphere Drug Delivery 
(DOX) 
PVA Passive  [119] 
11-15 Sphere Drug Delivery 
(DOX) 
Starch Passive  [92] 
10 Sphere Drug Delivery 
(DOX) 
PEG pH  [111] 
9.3 Sphere Drug Delivery 
(DOX) 
Oleic Acid Passive  [120] 
15 Sphere Drug Delivery 
(DOX) 
Dopamine 
HSA 
Passive  [121] 
8 Sphere Drug Delivery 
(DOX) 
None Passive  [122] 
5-10 Sphere Drug Delivery 
(PTX) 
NH2-terminated PEG Passive  [123] 
5 Sphere Drug Delivery 
(PTX) 
PEG Passive  [124] 
15-20 Sphere Drug Delivery 
(PTX) 
PLGA Passive  [125] 
150 Sphere Drug Delivery (Gene) PEI, PEG, Chitosan Passive  [126] 
15 Coating 
(Inverse core-
shell) 
Drug Delivery 
(Fluorescent Dye) 
Fe3O4 coating, PVP-
modified SiO2 core 
HFMF  [114] 
30 Sphere Drug Delivery 
(DOX) 
Hybrid Poymersome HFMF  [127] 
50 Sphere Drug Delivery (Gene) Dextran HFMF  [128] 
25 Sphere Drug Delivery (Vita B12) Hydrogel HFMF  [116] 
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8 Sphere Drug Delivery (TMX) Folic Acid, β-
cyclodextran 
HFMF  [129] 
10 Sphere Drug Delivery Eicosane HFMF  [130] 
2000 Cluster Drug Delivery 
(Budesonide) 
Lipid HFMF  [131] 
       
7 - 9 Sphere Hyperthermia Therapy 
(Cancer) 
PEG, Folic  
Acid 
HFMF  [113] 
10000 Cluster Hyperthermia Therapy 
(Antibacterial) 
None HFMF  [132] 
23600 Cluster Hyperthermia Therapy 
(Cancer) 
Silica HFMF  [133] 
6-20 Sphere Hyperthermia Therapy 
(Cancer) 
Silica, hydrogel HFMF  [134] 
60 – 80 Cluster Hyperthermia Therapy 
(Cancer) 
PEG, Folic Acid HFMF  [135] 
13 – 40 Cube Hyperthermia Therapy None HFMF  [136] 
5 Sphere Hyperthermia Therapy Hyaluronic acid, PEG HFMF  [137] 
45 Magnetosomes Hyperthermia Therapy Citrate, PEG HFMF  [138] 
12 Sphere MRI Autofluorescent Albumin - ATF [139] 
80 – 160 Cluster MRI Citrate - - [140] 
7.5 Sphere MRI Mercaptopropionic acid, 
dextran 
- - [141] 
6 Sphere MRI Folic Acid, PEG, PDLLA, - Folate [142] 
10 – 15 Sphere MRI Fluorescent Dextran  Protamine [143] 
10 Sphere MRI Targeting ligand  2-aminoethyl-trimethyl 
ammonium 
[144] 
  MRI   Glial fibrillary acidic 
protein 
[145] 
16 Sphere MRI Carboxylic manna  Mannose receptor [146] 
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1.3.4 Fe3O4-containing nanocomposites 
Composites nanostructures containing Fe3O4 are useful as they may add additional 
functionality and useful properties. Most notably, coating the iron oxide in a material 
such as silica or a suitable polymer may further improve the water-stability of the 
nanoparticle as well as its chemical inertness in biological conditions. For this reason, 
most composites of iron oxide focus on core-shell like structures, although other 
structures do exist. The synthesis of composite structures may be performed in two 
steps, whereby the Fe3O4 NPs are then combined with the second material or through a 
single-step co-synthesis where the two materials are formed simultaneously. The main 
structures currently known in literature have been illustrated below (Figure 4).  
 
Figure 4. Heterogeneous composite nanostructures of magnetite 
 
1.3.5 Composites with polypyrrole  
In this thesis, Fe3O4 is combined with polypyrrole to create structures that have 
magnetic functionality combined with the electrical, optical and thermal properties of 
polypyrrole. The known structures to date are simple core-shell, multiple core-shell, 
aggregated and raspberry-like structures (Figure 5).   
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Figure 5. Known structures of PPy-Fe3O4 nanocomposites. (a) core-shell[147], (b) aggregated[147], (c) 
multiple core-shell[148], (d) raspberry (PPy core, Fe3O4 decorations)[149] 
 
Composites of PPy and Fe3O4 may be synthesised by including suspended Fe3O4 
NPs in the chemical polymerisation mixture for PPy, in a process of seeded 
polymerisation. However, the resulting structures differ significantly depending on the 
particulars of the process. There are several important concepts to consider during such 
a two-step synthesis. Firstly, the degree of aggregation of the nanoparticles is important. 
For uniform core-shell structures, a highly desirable structure, the nanoparticles must be 
well-dispersed during synthesis. Secondly, both the location and type of nucleation of 
the PPy particles is important. For example, a homogeneous nucleation that is not 
concentrated at the Fe3O4 nanoparticle surfaces will result in randomly aggregated 
structures.  
Indeed, it has been reported that when synthesised without surfactants to prevent 
the aggregation of Fe3O4 NPs, an aggregated structure comprising polypyrrole NPs that 
nucleates away from the Fe3O4 surface results (Fig. 4 b) whereas the inclusion of a 
surfactant such as sodium dodecyl sulfonate will promote a core-shell structure 
comprising a homogenous polypyrrole layer over the nanoparticle cores.[147] The use of 
a copolymer such as PVA may have a similar effect in promoting the growth of the 
core-shells[148]. Wuang et al. combined typical oxidation route with PVA-based 
microemulsions  to create PPy particles with multiple encased Fe3O4 cores.[150] Tian et 
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al.[149] was able to create the reverse, raspberry-like structure of PPy serves surrounded 
by Fe3O4 decorations on the structure surface by applying using an FeCl3.6H2O oxidant 
in excess and applying a second step to convert excess Fe3+ into Fe3O4 nanoparticles.  
The oxidant used will also have an effect on the structure. While both APS and 
FeCl3.6H2O are commonly used in oxidation of polypyrrole, in the synthesis of PPy-
Fe3O4 composites the use of FeCl3.6H2O may be advantageous due to the common ion 
effect. It is hypothesised that Fe3+(aq) adsorbs on the Fe3O4 nanoparticle surfaces, thus 
promoting the polymerisation of PPy at the nanoparticle surface.[148]  
1.3.6 Magnetically-driven synthesis and self-assembly 
One concept that is unique to magnetic nanomaterials is the use of a magnetic field 
during their synthesis to promote the growth and/or assembly of 1-dimensional, 
anisotropic nanostructures along the direction of the field lines. This process involves 
the transport and arrangement of matter under an applied magnetic field. This may be 
follow by or occur simultaneously with stabilization of the assembled structure by 
chemical means. Before discussing the recent progresses in this area, it is important to 
understand the fundamental underlying theories governing this process. 
Firstly, the movement of transition metal ions in a solution is governed by the 
magnetic force, F(z) defined as  
𝐹𝐹 (𝑧𝑧) =  𝜒𝜒𝜒𝜒𝐻𝐻(𝑧𝑧) 𝜕𝜕𝜕𝜕(𝑧𝑧)
𝜕𝜕𝑧𝑧
                              (Equation 3) 
Where χ is the molar magnetic susceptibility of metal ions with mole number n at the 
position z within a magnetic field H(z). Hence, it has been observed that larger 
movement under the same field gradient occurs for ions of larger susceptibility[151]. At 
the same time, a larger overall ion concentration induced larger movement, which 
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indicates that the ions move as a group and not as independent single particles. The drift 
velocity of these ions, v(z), has the following simple relationship to the magnetic force.  
𝑣𝑣(𝑧𝑧) ∝ 𝐹𝐹(𝑧𝑧)                                     (Equation 4) 
The movement of ions is in line with the magnetic field, with overall migration towards 
the centre of the field. This results in the formation of 1D structures along the field 
lines. These two equations govern the transport component. The energy component is 
governed by the following equation for the magnetic energy E of an object of volume V 
under a magnetic field B through a space of permittivity μ0:  
𝐸𝐸 =  1
2𝜇𝜇0
𝜒𝜒𝜒𝜒𝐵𝐵2                                      (Equation 5) 
If the magnetic energy is greater than that of the thermal energy for a system, the 
objects will orient to the applied field. Since magnetic properties are anisotropic within 
a crystalline grain, they will do so by orienting in the crystal direction that will 
minimise the energy of the system. This direction is called the ‘easy direction’. In 
Fe3O4, the easy magnetic axes are along [111] and [110] directions.  
These fundamental forces are utilized in nature within magnetotectic bacteria. 
This class of bacteria form chains of magnetic nanomaterials within their bodies. It is 
currently understood that these anisotropic magnetic nanostructures, called 
magnetosomes, aid the bacteria in finding their orientation within the earth’s magnetic 
field (Figure 6). Some attempts have been made to harvest these magnetosomes and 
apply them subsequently to biomedical applications[152] such as delivery of DOX[153] 
and magnetothermal therapy.[138] However, due to the need for culturing, harvesting and 
purification of these magnetosomes, there has emerged a recent interest in artificially 
synthesising analogous materials.  
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Figure 6. Transmission electron microscopy images of a single magnetotactic bacterium (A) of chains of 
magnetosomes extracted from whole magnetotactic bacteria (B) of individual magnetosomes detached 
from the chains by heat and SDS treatment (C).[152] 
 
Figure 7. Schematic illustrating various known 1D structures resulting from synthesis under an applied 
magnetic field. (a) single crystal nanowire, (b) multi-crystal nanowire, (c) bundled nanowire, (d) 
nanochain of isotropic nanoparticles, (e) aggregated chain.  
 
The current work on the synthesis of anisotropic magnetic materials under an 
applied magnetic field may be divided into several categories depending on the resulting 
morphology. The two main structures are rod-like (Figure 7 a,b) and chain-like (Figure 
7 c). Of course, as for all nanomaterials, the tendency to form aggregates (Figure 7 c,e) 
is ever present. 
Rod-like or wire-like structures are typically synthesised in one step, coupling 
an applied magnetic field with a typically liquid phase synthesis of iron oxides. For 
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example, Wang et al. have reported the fabrication of single crystal Fe3O4 nanowires by 
hydrothermal process by applying a field of up to 0.35T. [154] The nanowire that resulted 
was found to grow primarily along the [110] direction and is in good agreement with the 
theory discussed above of ion migration along magnetic field lines during synthesis. 
Similar results were observed for sonochemical[155] and thermal decomposition[156] 
synthesis. It is similarly possible to create multi-crystalline nanowires and rods by such 
one-step methods under certain, kinetic driven conditions.[157]  
In addition to rod or wirelike materials, application of a magnetic field can also 
be used to assemble individual isotropic (usually spheroid) nanoparticles into 1D, 
chainlike forms. These structures may be understood to form in a two-step process. 
First, the nanoparticles are formed without the influence of a magnetic field, and then 
arranged under the aligning magnetic field. This is typically accomplished in the liquid 
phase with suitable surface treatment of the magnetic nanoparticles for either colloidal 
stability or as an adhesive coating to stabilize the assembled anisotropic structures. For 
example, Chong et al. were able to create end-on-end, well-dispersed nanochains with 
tuneable size by encapsulating Fe3O4 NPs with SiO2 in a microfluidic reactor.[158]  
The key publications of the past decade in magnetic field directed synthesis have 
been summarized in the following table (Table 3).   
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Table 3. Magnetically directed synthesis of anisotropic materials 
 Method Material Field Strength 
(T) 
Source 
Li
qu
id
 P
ha
se
 
Hydrothermal Single crystal Fe3O4 nanowire 0.25 [154] 
Hydrothermal Fe3S4 and FeS2 multi-crystal 
microrods 
0.045 [159] 
Hydrothermal Co3O4 nanowire 0.24 [160] 
Sol-gel TiO2 nanowires 9.4 [161] 
Solvothermal Bi single crystal nanowires 8 [162] 
Solvothermal Ni-Co alloy nanowires 0.08 [115] 
Sonochemical Fe3O4 nanorods 0.5 [155] 
Microwave Fe3O4/C/CdS coaxial 
nanochains 
0.2 [163] 
Wet chemistry Ni nanochains 0.5 [164] 
Wet chemistry PEDOT:PSS encapsulated iron 
oxide NPs nanochains 
0.065 [165] 
Wet chemistry 
microfluidic 
SiO2 encapusulated Fe3O4 NPs 
nanochains 
Unreported [158] 
Wet chemistry 
nanocapillary 
coating 
Fatty acid encapsulated Fe3O4 
NPs nanochains 
0.0012 [166] 
V
ap
or
 P
ha
se
 
Chemical Vapor 
Deposition 
GaN nanowire 0.25 – 0.8 [167] 
Arc Plasma SWCNT 0.02- 0.2 [168] 
Flame synthesis Co multi-crystal nanowire 1 [157] 
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This present work is particularly interested in the synthesis of chainlike and 
aggregated chainlike structures. Unlike the rod-like counterparts, these chains can be 
flexible when a suitably soft material is chosen as the encapsulating agent. For example, 
Ho et al. was able to create conductive, flexible filaments of iron oxides by using 
conductive polymer PEDOT:PSS as the coating material. [165] Of course, when a rigid 
material such as SiO2 is used as the coating instead, the resulting nanoparticle chains are 
as rigid as expected.[158] Additionally, the assembly of magnetic nanochains may be 
engineered to be reversible. Bharti et al. coated iron oxide chains with fatty acids to 
create a thermally-responsive material that would be reconfigurable when the fatty acid 
was in liquid state and exploited this for magnetically directed self-healing of the 
filaments.[166]  
In addition to end-on-end chains of single particles, it is possible to create large, 
needle-like structures that result from the aggregation of large numbers of nanoparticles 
in the direction of the magnetic field.[169] These structures are termed ‘needle-like’ due 
to the profile of the structure’s width dimension, comprising a middle section of several 
nanoparticles’ width that tapers to a fine, needle-like point (Figure 8). At present, it is 
unclear what experimental conditions cause these two vastly different reported 
morphologies, and how conditions may be selectively and controllably exploited to 
favour one over the other.  
Finally, it is important to consider the dynamic behaviour of the chainlike 
materials, in particular the soft, flexible materials. Bharti et al.[169] have reported a 
flexible, curling motion (Figure 10) that is unique to soft-coated nanochains and is not, 
for example, observable in the SiO2-encapsulated chains presented by Chong et al.[158] 
Although the irreversible formation of circular bundles reported by Bharti may be a 
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disadvantage as it destroys the anisotropy of the structure, it is nonetheless an 
interesting and unique material property. At the very least, this work indicates the 
importance of tracking the dynamic behaviour of such structures which can be 
demonstrably irreversible.  
 
Figure 8. Formation of aggregated nanochains under an applied magnetic field.[169] 
 
Figure 9. Flexible motion of soft-encapsulated nanochains[169] 
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Figure 10. Irreversible formation of spheroid bundles upon applying a rotating magnetic field.[169] 
 
To date, the synthesis and assembly of 1D nanomaterials under a magnetic field 
remains relatively novel, despite the potential of such materials in numerous areas. For 
the purpose of this work, it is the potential of such materials towards drug delivery that 
is important. Anisotropic materials that may be magnetically actuated have numerous 
potentially useful properties. Firstly, they may be arranged or patterned by external 
magnetic field alignment. The ability to create aligned structures for drug delivery has 
been of interest recently, in particular in scaffolds for neuron growth. The ability to 
promote neurite extension in one direction by using a suitably patterned nano- or micro- 
vehicle loaded with a neural growth factor is an area of high novelty and high impact 
research. 1D magnetic nanomaterials have a strong advantage over scaffold and coating 
system as they have the potential for dynamic response. While scaffolds are fixed, 
nanowires and chains can be manipulated at will by applying a simple change to the 
magnetic field strength or direction. To date, there have been no attempts to study what 
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the effect of controlled movement of the cell substrate would be on the resulting cell 
growth pattern.  
The second useful property arises from the movement of the 1D structures when 
subjected to a rotating magnetic field. They are reported to follow the movement of the 
field direction and have been proposed by Chong et al. to be useful as nanoscale 
impellers inducing formation of local vortices.[158] While Chong et al. suggest the 
application of these vortices for microscale mixing to be used in lab-on-chip and other 
miniaturised systems, this function may also be of interest in drug delivery and other 
therapies. Firstly, the rotation of the 1D nanostructures induces local turbulence that 
may overcome the typical diffusion limitation of drug delivery systems. Secondly, the 
high speed rotating action itself may be used for therapy for targeted cell destruction. It 
has been recently discovered that physically breaking apart the cell walls of bacteria 
using a nanomachine may be highly effective at defeating pathogens.[170]  Although no 
parallel studies have been conducted so far on using a similar mechanism for cancer 
therapies, this is potentially an area of high impact research.  
1.4 Synthesis of Metal Oxide Nanomaterials  
There are currently many methods to synthesise the metal oxide nanoparticles discussed 
in previous sections. The most important methods have been categorised in the 
following figure (Figure 11).  
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Bac 
Figure 11. Synthesis methods for metal oxide nanomaterials  
Currently, the chemical methods dominate the field. Each technique brings its own 
advantages and disadvantages, possibilities and limitations. Useful parameters to 
consider include speed and throughput, scalability, toxicity of materials involved, 
energy consumption, and resulting particle size, shape and uniformity. A brief 
comparison of the key chemical synthesis routes for TiO2, SiO2 and Fe3O4 follow 
(Table 4).  
1.4.1 Flame Spray Pyrolysis  
The dominant nanoparticle production method of this thesis is flame spray pyrolysis. It 
is a high throughput, low cost method that is able to create high purity nanoparticles of a 
suitable size scale (typically 5- 50 nm) in one step[171]. This method involves a 
combustible precursor containing the metal ions diluted in a highly flammable fuel 
(commonly ethanol[172], acetonitrile[173] or xylene[174]) that is injected through a nozzle 
with oxygen jets. An aerosol of fine precursor droplets is formed. This is then 
combusted by a continuous gas-fed flamelets that surround the aerosol, resulting in the 
production of metal oxides. These metal oxides nucleate to form nanoparticles that then 
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continue to collide and grow to their final size. They are driven to the cooled collection 
region by thermophoresis, forming a film with porosity typically in the range of 
98%[175],and their collection may be aided by vacuum filtration. A schematic 
representation of a typical FSP reactor along with the growth mechanism of 
nanoparticles is provided below (Figure 12).  
 
Figure 12. (a) Schematic representation of a typical FSP reactor. (b) TEM showing typical TiO2 product 
and (c) SEM showing top view of porous film of the same.  
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Table 4. A brief comparison of different chemical routes towards MOx nanomaterial synthesis 
Technique Description Advantage Limitation 
Chemical Vapor 
Deposition 
Volatile precursors decompose and/ or react on a 
substrate surface to form desired products. 
Highly uniform, 1D structures can 
be grown this way if using seeds. 
High cost and low throughput. 
When unseeded, only films can 
be made this way. 
Flame Spray 
Pyroloysis 
Liquid precursors are combusted in a high 
temperature flame, creating nanomaterials, usually 
oxides. 
High throughput 
Low cost 
High purity and crystallinity 
Products are polydisperse. 
Some irreversible agglomeration 
to be expected. 
Sol-gel Precursor solution is mixed with a suitable catalyst 
slowly evolves into a gel-like state containing 
discrete nanoparticles in a polymer matrix. 
Low cost and low tech. A second, high temperature 
stage must be applied to purify 
the product. 
This can be a slow method. 
Precipitation Solution containing the nanomaterial precursors is 
mixed with a suitable initializer (e.g. oxidising/ 
reducing agent) to form precipitates. 
Fast and easy. 
Scalable. 
Controlled growth can be 
difficult. Particle size can be 
large and polydisperse. 
Micelle Two phase system of microdroplets of oil suspended 
in water is created. Nanoparticles are synthesised at 
the surface between the two phases. 
Excellent control over shape and 
size is possible. Products can be 
monodisperse. 
Currently only small-scale batch 
synthesis can be achieved. 
Electrochemical Eletrolyte containing precursor ions is either 
oxidised or reduced at the appropriate electrode to 
form solid material. 
1D structure can be achieved by 
templating. 
Cannot be used to create 
nanostructures without 
appropriate templating, only 
films. 
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The synthesis of both TiO2 and SiO2 by FSP are relatively well-established, therefore 
this thesis will not be concerned with optimising this known procedure. From the 
previous work, the following relevant and useful observations arise:  
i. The resulting particle size scales with the concentration of the metal ion over 
the dispersing oxygen [M]/O2.[172] In other words, at a given precursor 
concentration and system pressure drop, the greater the dispersion oxygen, 
the smaller the particle size.   
ii. Typical particle size is between 5 – 50nm for SiO2[172], 5 – 20m for TiO2[176] 
and 5- 50nm for iron oxides.[177] In all cases, there is a significant particle 
size distribution within the sample that may be attributable to natural 
temperature profile within the flame.  
iii. Some degree of hard agglomeration is expected due to the collision and 
subsequent sintering together of particles within the high temperature zone 
in the flame. Typical agglomerate size is between 100 – 200nm. This 
agglomeration is distinct from the van der Waals driven flocculation of 
nanoparticles as it is typically irreversible/ unbreakable even at high 
pressure.[178]  
iv. TiO2 is produced as mixtures of Anatase and Rutile. Particle shape is 
expected to be facetted spheroid.[179]  
v. SiO2 is usually produced as spherical amorphous particles.[180] However, 
nanowires have also been observed.[181]  
vi. Iron oxides are produced in Maghemite, Wustite and Magnetite forms.[177] 
The synthesis of iron oxides is less advanced than wither TiO2 or SiO2 and is 
worth studying.   
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1.5 Functionalising metal oxide nanomaterials 
Previously, the concept of using an appropriate tethering or gating molecule to improve 
the performance of the nanocarrier has been introduced. The functionalisation of 
nanoparticle surfaces with such suitable organic molecules is in itself an interesting and 
active research field due to the applicability of functionalised nanomaterials for 
biosensing[182], implant integration[183], bio-labelling[184], and, of course, drug 
delivery[185]. This section will outline the key concepts of this field in detail, with a 
particular focus on the interaction of amino acids with MOx surfaces.  
There are several general design considerations to be applied when choosing a 
suitable functional molecule, which may be simplistically understood to possess a head 
group (for the attachment of the target molecule to be delivered) and an anchor group 
(for attaching to the nanoparticle vehicle) connected by the spacer chain.  
i. Anchor group. The role of this group is to form the bond between the surface of 
the nanostructure and the molecule. Different interactions are possible, including 
covalent[186], hydrogen[187] and electrostatic bonding[188]. There has been 
extensive study conducted on the adsorption mechanism of ceramic surfaces 
with various functional groups, most significantly carboxylates[189], amines[190], 
phosphonates[191] and silanes[192].  
ii. Head group. This group should be tailored to suit the final application. The head 
group, being the group that is ultimately exposed to the surroundings, has a large 
role in the overall chemistry of the resulting functionalised material. For 
example, a nanoparticle may change from negative to positive surface charge[193] 
and from hydrophilic to hydrophobic[194] due to the action of this head group. In 
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this dissertation, carboxylate sand amines are considered due to the affinity of 
these groups towards proteins[195] and DNA[196] which renders them highly 
versatile within the fields of drug delivery and gene transfection.  
iii. Spacer. The shape and length of the chain may have a small steric-limiting effect 
on the density of functional molecules attached to the nanostructure surface. For 
example, small linear molecules may show higher packing density than large, 
laterally bulky counterparts.[197]  
 
Figure 13. A nanoparticle of 5 nm with different ligand molecules. Left to right: trioctylphosphine oxide 
(TOPO), triphenylphosphine (TPP), dodecanethiol (DDT), tetraoctylammonium bromide (TOAB) and 
oleic acid (OA). [198] 
 
1.5.1 Phosphonates 
Metal oxide nanoparticle surfaces may be modified with phosphonates (-PO3) resulting 
in mono-, bi- or tridentate anchorage of a phosphonate ligand on the metal oxide 
surface, creating a M-O-P bond. This can generally be accomplished using P-OH, P-OR 
or P-O- containing precursors. One example is the reaction of TiO2 with phosphonic 
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acid[199], resulting in a Ti-O-P bond that is very stable toward hydrolysis. Conversely, 
the Si-O-P bond is highly sensitive to hydrolysis and is not stable[200].  
 
Figure 14. Phosphonate interaction with TiO2 surface. From left to right: mono-, bi- and tridentate 
anchorage. Adapted from Neouze and Shubert.[201]  
1.5.2 Silanes 
Silanes are amongst the most common used functional molecules for MOx surfaces due 
to the large variety of commercially available silanes (e.g. alkoxysilane, 
hydrogenosilane or chlorosilane) bearing different head groups (e.g. amino, cyano, 
carboxylic, epoxy) and their relatively easy grafting pathway. In particular, di- and 
trichlorsilanes are so reactive towards MOx surfaces that multidentate attachments are 
favoured.[202, 203] This functionalisation is currently known for many metal oxides, 
including TiO2[204], SiO2[205] and Fe3O4[206].  
1.5.3 Carboxylates 
Carboxylic acids (-COOH) are commonly used for modifying MOx nanoparticles, 
particularly long-chain acids such as oleic acid which can be used to cap Fe3O4[207]. 
Several interactions are possible, including physical adsorption and several 
chemisorption forms (Figure 14). It has been reported that normal post-modification of 
metal oxide nanoparticles such as titanium dioxide by immersion in aqueous solutions 
containing the modifying functional molecule will result in simple physisorption by 
electrostatic or H-bonding rather than chemisorption.[208] 
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Figure 15. Carboxylate interaction with TiO2 surface. From left to right: physical adsorption, 
monodentate coordination, bridging chemisorption, chelating chemisorption.[201]  
1.5.4 Amines 
The interaction between amines (-NH2) and metal oxides is usually via electrostatic 
attraction[209] or hydrogen bonding, and is therefore weaker than the chemisorption 
configurations of the other anchor groups so far presented. For this reason, it is not 
common to make use of amine adsorption for functionalization of MOx nanoparticles.   
1.5.5 Amino Acids  
Due to the bio-interfacing potential of amino acids[210], the adsorption of these 
biologically important molecules onto the surfaces of metal oxide nanostructures has 
become an area of emerging importance in surface science. Amino acids are amphoteric, 
possessing both basic primary amine (-NH2) and carboxylic acid (-COOH) groups and 
may thus undergo the bonding configurations typical of both of these anchor groups. 
This leads to several different possible binding mechanisms that are of fundamental 
interest.[211]  
In the past two decades, there have been advances both empirically and 
theoretically on the adsorption of particularly important amino acids on likewise 
significant metal oxide surfaces (e.g. TiO2, Fe3O4), although there remains a deficit in 
the empirical verification of adsorption models within the same study. At the same time, 
there is some disagreement in the data thus far collected. For example, it still remains 
unclear whether simple electrostatic attraction between metal oxide surfaces and 
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charged amino acids is the primary driver[212], or whether the adsorption pathway by 
replacing surface hydroxyls by the carboxylate group of the amino acid is in fact 
favoured[213]. 
The field is still waiting for a definitive study that unifies theories and data to 
date with a view towards explaining the precise mechanism of this pH-dependence as it 
relates to various bonding hypotheses. Furthermore, there have been few attempts to 
apply the key results to the optimisation of such structures towards biomedical 
applications where binding configuration and its resulting effects on such properties as 
surface charge, particle agglomeration/coagulation, and amino acid bond strength, 
although these factors have proven importance for cellular uptake[214] and 
toxicology[215]. 
A summary of the important works to date that have been included in this review 
are presented in Table 5.  
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Table 5. Key studies on interaction of metal oxide surfaces with amino acids 
Metal 
Oxide 
 Amino Acid Theoretical/ Empirical Key Findings  Source 
TiO2 
 
Glutamic Acid 
Aspartic Acid 
Empirical (IR) Aspartic acid adsorbs via electrostatic interaction 
Glutamic acid adsorbs strongly even when there is 
electrostatic repulsion. 
 [212] 
TiO2 Methionine 
Alanine 
Empirical (XPS) Amino acids generally tend to adsorb onto TiO2 surfaces 
by their carboxyl groups replacing a basic hydroxyl on a 
Ti site, a process favoured by acidic milieu. 
 [213] 
TiO2 Lysine Empirical (IR) Lysine is maximally adsorbed near its isoelectric point 
of 9.8. 
 [188] 
TiO2 
 
Aspartic Acid 
Homocysteine 
Lysine 
Serine 
Empirical (X-ray photoelectron 
spectroscopy) 
Most amino acids prefer to bind by the –COOH in acidic 
medium. 
At pH>6, Lysine interaction by –NH2 dominates. 
 [216] 
TiO2 
 
Glycine 
Aliphatic 
carboxylic acids 
Empirical (IR) 
Theoretical (quantum-chemical 
calculations) 
Carboxyl groups prefer bridge and monodendate 
binding. 
 [217] 
TiO2 
 
Alanine 
Phenlyalanine 
Serine 
Aspartic Acid 
Histidine 
Empirical (Zeta Potential -OH (Ser), -NH (Trp, His), or -NH2 (Asn) in their side 
chain appeared to be adsorbed more favorably 
 [218] 
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TiO2 
 
Lysine 
Polylysine 
Empirical (IR) Electrostatic interactions of the lysine peptides with the 
adsorbent are of main importance to adsorption. 
  
Fe3O4 Aspartic Acid 
Glutamic Acid 
Empirical (IR) Chemisorption of chelate type involving Fe(III) surface 
species and a carboxylate group. 
 [219] 
Fe3O4 Glycine 
Glutamic Acid 
Lysine 
Arginine 
 
Empirical (electrophoretic 
mobility) 
Electrostatic interactions only considered.  [209] 
Fe3O4 Cysteine Empirical (IR, Mossbauer) Both carboxyl and amine groups are involved.  [220] 
Fe3O4 Aspartic Acid 
Leucine 
Glycine 
Glutamic Acid 
Theoretical (Force-field 
calculations) 
Electrostatic interactions dominate. Carboxyl-group 
(Asp and Glu) or to the carboxylate-group (Gly, Leu and 
Glu) are involved. 
 [221] 
Fe3O4 Lysine 
Glutamic Acid 
Empirical (Zeta Potential) Carboxyl is preferred.  [222] 
Fe3O4 Aspartic Acid 
Lysine 
Empirical (Zeta Potential) Carboxyl is preferred.  [223] 
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1.5.6 Reaction pH and amino acid functionalisation  
One of the most important parameters to consider in the binding of amino acids to MOx 
surfaces is that of the amino acid charge state as this determines the electrostatic 
attraction between the molecule functional groups and the metal oxide, a crucial step in 
the binding process. The protonation/deprotonation of the –NH2/COOH groups is 
strongly pH-dependant and thus the overall charge of the molecule may be controlled by 
selectively adjusting the pH relative to the pKa values for each of the functional groups 
of the amino acid. Figure 16 shows the pKa values of several biologically important 
amino acids.  
This pH-dependence is significant on three accounts. Firstly, it can be 
manipulated during synthesis to encourage certain interactions. Secondly, the net 
surface charge of any nanomaterials coated in amino acids can by tuned by changing the 
pH. And finally, it is important to be aware that under physiological pH 7.4, which is the 
ultimate environmental pH for most biomedical applications, most amino acids will 
exist in their zwitterionic form. This is important as amino acids in their zwitterionic 
form will be able to associate together by electrostatic interactions, causing adsorption 
of multiple layers of the molecules on the particle surface (Figure 17).[223] This is 
important to consider when designing nanostructures using amino acids as the 
functional coating as, depending on the final surface chemistry of the structure, there 
may be significant agglomeration of nanoparticles via this association mechanism. The 
association of nanoparticles into larger, microscale structures is often presented as a 
disadvantage due to the loss of the nanoscale functions, but in fact there may also be 
useful outcomes of this property, when this association can be controlled.  
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Figure 16. pKa and charge state for various amino acids (adapted from[224]) 
 
 
Figure 17. Association of amino acids in zwitterionic form (Adapted from [223]). 
 
The second component of the adsorption interaction is the metal oxide surface, which is 
likewise pH-responsive. As for the amino acid, the metal oxide surface is also 
amphoteric[225] in nature and its overall net charge of the metal oxide in aqueous 
environment is pH-tuneable[226]. The isoelectric point (IEP) of the metal oxides studied 
in this thesis, magnetite and anatase form of titania, have been summarised below 
(Table 6). Magnetite and anatase (and metal oxides in general) present a negative charge 
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at pH above the IEP and a positive charge at pH below this crucial point. Understanding 
of the surface charge of the nanoparticle is also an important method to characterise 
their degree of functionalisation. Upon adsorption of functional molecules, a shift in 
isoelectric point is useful in first assessing the successful binding of the modifying 
ligand, and is further significant in charge-dependant processes such as protein 
adsorption.[193]  
Table 6. Isoelectric point of iron and titanium oxides 
Material Isoelectric Point Source 
Fe3O4 6.8 [227] 
Fe3O4 6.78 [228] 
Fe3O4 6 [229] 
Fe3O4 6.78 [230] 
TiO2 (Anatase) 5.8 [231] 
TiO2 (Anatase) 5.5 [232] 
TiO2(Anatase) 5.3 [233] 
TiO2(Anatase) 5.5 [234] 
TiO2 (Rutile) 3.2 [232] 
 
In addition to the physi- and chemisorption configurations that can be expected 
from interaction with either the –COOH or –NH2 group, the amino acid can also be 
involved in electrostatic interactions governed by the reaction pH and the overall 
charges of the molecule and the MOx surface. For example, it has been noted that the 
adsorption of L-aspartine[235] and L-glutamic acid[236] onto TiO2 is promoted at a pH 
where the two bodies carry attractive opposite charges and is conversely inhibited when 
they carry repulsive like charges. It is important to realise that the local charge at the 
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functional group(s) of the amino acid may be more important than overall charge of the 
molecule. For example, although the zwitterion is neutral, the local charged -NH3+/-
COO- groups may still interact with the charged metal oxide surface.  
 
Figure 18.  Electrostatic binding of amino acids to (a) negatively charged and (b) positively charge metal 
oxide nanoparticle surfaces.  
 
In amino acids containing more than one –COOH group (such as glutamic acid), 
both carboxyls may be involved simultaneously in coordinating to the metal oxide 
surface. In fact, in glutamic acid, it is currently understood that this double binding 
action is dominant. This has an important implication on the overall surface chemistry 
of the resulting functionalised structure. Firstly, this will affect the zeta potential. A 
glutamate molecule that is bound by a single –COO- will present an overall net neutral 
charge (due to remaining free –COO-/NH3+), whereas one undergoing bidentate binding 
will present a net positive surface charge. Additionally, the bidentate binding 
configuration is more robust than the single-site binding. Both of these considerations 
are important for biomedical applications where the surface charge is crucial in 
determining both the interaction with biological moieties (e.g. DNA, protein binding) 
and the strength of the tethering functional molecule determines the robustness of the 
overall structure.  
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1.6 Intrinsically Conductive Polymers 
The third type of nanomaterial of great biomedical importance is the class of 
intrinsically conductive polymers. They provide alternative routes towards controlled 
drug release via their unique photo thermal and electrochemical properties. As their 
name suggests, this class of materials is usually conductive with a switchable 
conductivity that is based on their oxidation state[237]. This ability to switch is the basis 
behind their electrochemically triggered drug release[238]. They have low energy 
bandgap transitions available, typically absorbing light in the visible and near 
infrared[239], compared with UV for TiO2, and transforms this absorbed light into a local 
temperature increase[240] that can in turn trigger any nearby temperature-sensitive 
components[241].  
The most important conductive polymers are:  
(i) Polypyrrole (PPy) 
This is arguably the most well-studied polymer for biomedical applications, due in part 
to its good in vitro and in vivo biocompability[242], good chemical stability in water[243] 
and relative ease of synthesis.  
 
Figure 19.Chemical structure of polypyrrole (PPy). 
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(ii) Polyaniline (PANI) 
The second most investigated after polypyrrole is polyaniline, which exists in in the 
following forms: pernigraniline base, half-oxidised emeraldine base, and fully reduced 
leucoemeraldine base[244]. These forms differ significantly in their conductivity, and 
electrochemical means may be used to switch readily between the forms.  
 
Figure 20. Chemical structure of polyaniline (PANI) 
(iii) Poly(3,4-ethyl-enedioxthiophene) (PEDOT) 
A third alternative is PEDOT, a polythiophene derivative that has better 
conductivity[245], but is less thermally stable.[246]  
 
Figure 21. Chemical structure of PEDOT 
 
1.6.1 Polypyrrole Synthesis  
This dissertation focusses primarily on PPy due to its proven biocompatibility and easy 
route of synthesis that can readily be adapted to produce nanocomposites with the other 
materials of interest[247]. There are two routes towards the synthesis of polypyrrole: 
chemical and electrochemical polymerisation. In both cases, the monomer pyrrole is 
oxidised to produce a positively charged polymer backbone that is stabilised by the 
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inclusion of anions[248]. In the case of chemical polymerisation, a strong oxidant, 
typically ammonium persulfate (APS)[249] or iron (III) chloride hexahydrate 
(FeCl3.6H2O)[250] is used to initiate the reaction and counter ions included in the 
resulting product are the anions from this salt, sulphates (SO42-) and chloride (Cl-) 
respectively. Synthesis via the chemical route produces nanoscale polypyrrole particles 
in one step and is therefore a facile route that is preferred for drug delivery applications. 
Electrochemical synthesis uses applied potential (> 0.8V) as the driving force for 
oxidative polymerisation[251]. This method produces a coating of polypyrrole on the 
working electrode and is often used for coating of implants[252]. A schematic for the 
general reaction pathway resulting in oxidised polypyrrole has been included below 
(Figure 22).  
 
Figure 22. Polymerisation of polypyrrole by either electrochemical or chemical pathway.  
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Chemical routes are used in this work due to the ease at which these methods can be 
adapted to create functional nanocomposite structures applicable for drug delivery 
applications as compared with the bulk scale deposited film that typically result from 
electrochemical synthesis.  
1.6.2 Electrochromic properties 
The oxidised form of polypyrrole is also referred to as ‘doped’ polypyrrole due to the 
inclusion of the anionic dopants. In the doped form, the polymer is conductive due to 
the formation of polarons (single positive charges) or bipolarons (double positive 
charges) spread over four pyrrole units, whose distortion in the polymer chain relaxes 
the high stresses within the five member ring and thus create lower energy states below 
the conduction band.[253] Bredas et al’s landmark investigation on the evolution of the 
band structure upon successive doping show that the main gap at 3.2 eV of undoped 
PPy is joined by additional transitions at 0.7 eV, 1.4  eV and 2.1 eV.[254] Thus, a doped 
polypyrrole absorbs strongly in visible and near infrared ranges. Furthermore, PPy is 
electrochromic, that is, its optical and electrical properties are strongly linked. For this 
reason, the optical absorbance of a PPy sample is a useful tool to determine the 
sample’s oxidation state and doping content. [255-258] 
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Figure 23. Evolution of optical absorbance of polypyrrole upon successive doping content.[254] 
 
1.6.3 Doping and dedoping  
There has bene a recent push towards doping PPy with useful anionic molecules instead 
of the anions from the oxidant salt or electrolytes to create electrochemically triggered 
load and release systems. This can be accomplished by including a suitable, negatively 
charged molecule in the typical polypyrrole synthesis, whether it be by the chemical or 
electrochemical route. Examples include biotin[259], dexamethasone[260] and neurotrophic 
proteins[261], all of which can be successfully incorporated in the PPy by including the 
dopant in the reaction mixture at the point of polymerisation. This versatility has led to 
the proposal of PPy as a material for drug delivery[262] in both its nanoparticle and film 
forms. The ability to include proteins, particularly growth factors,[263] makes PPy a 
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preferred material for implant coating as these bound growth factors can significantly 
increase the growth of cells over the PPy surface and thus implant integration is 
improved[264].  
These materials may be subsequently dedoped in one of two methods.  The most 
common is to forcibly reduce the PPy by applying negative potential. This neutralises 
the charge on the polymer backbone and forcibly ejects the bound anion.[265] 
Electrochemical dedoping has proven to have a high efficiency and is a preferred 
method for drug delivery from polypyrrole films[238]. Although this is most applicable to 
electrodes coated in the PPy, there has been a recent landmark study using electric field 
penetration in vivo to accomplish the same on PPy nanoparticles.[266]  Dedoping can 
also be triggered by changes in pH. It has been observed that treatment with alkaline 
media will also result in removal of the dopants[267]. This gradual loss of bound anions 
has also been observed at physiological pH (in PBS) and has been utilized for the 
gradual, passive release of bound anti-inflammatory drugs.[268]  
 
1.6.4. Photothermal responses 
In addition to electrochemical triggers, PPy also has a strong photo-responsive to light 
matching the wavelengths of its main bands (0.7eV, 1.4eV, 2.1eV and 3.2eV). Its 
photothermal response (a conversion of this absorbed light into local increases in 
temperature) has been well-documented This has been used directly for photothermal 
therapies such as the ablation of cancer cells.[240] Additionally, this local increase in 
temperature can be used in conjunction with temperature-sensitive components such as 
labile linkers[241] and hydrogels[269] for controlled release.  
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1.6.5. Polypyrrole and amino acids 
As for TiO2 and Fe3O4, the use of amino acids with polypyrrole has garnered some 
interest in recent years due to their biological importance coupled with their amphoteric 
and sometimes ambiguous chemistry. Overall, work in this area is rather limited 
compared with metal oxide functionalisation. Meteleva-Fischer et al. first observed that 
glutamic ions could be incorporated in electrochemically synthesised PPy[270], and 
Valencia et al. subsequently reported that their inclusion served as a tethering point for 
the controlled release of amoxicillin.[271] However, these works stand alone in the 
literature and do not present any detailed, systematic study of how this doping may be 
optimised.  
1.6.6 Literature survey of polypyrrole as a nanocarrier 
A literature survey is presented below ( Table 7) for the current biomedically important 
results pertaining to PPy. 
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Table 7. Polypyrrole for biomedical applications 
 
Structure Synthesis Route  
Dopant 
Application Mechanism Source 
Hollow Sphere Chemical Di(2-ethylhexyl) 
sulfoscuccinate 
Photothermal ablation 
 
NIR laser 
(808nm) 
[272] 
Sphere, 45nm Chemical Cl- Photothermal ablation NIR laser 
(808nm) 
[273] 
Sphere, 100nm Chemical Cl- Photothermal ablation NIR laser 
(808nm) 
[274] 
Sphere 
50nm 
Chemical Cl- Photothermal ablation NIR laser 
(808nm) 
[275] 
PPy on Mesoporous Silica Chemical Cl- Photothermal ablation NIR laser 
(808nm) 
[276] 
Sphere, 85nm Chemical SO42- Photothermal release 
( FITC-albumin) 
NIR laser 
(808nm) 
[277] 
Sphere, 27nm Chemical Cl- Photothermal release 
(Vancomycin) 
NIR laser 
(808nm) 
[278] 
Hollow Sphere Chemical SO42- Photothermal release NIR laser 
(808nm) 
[279] 
Film Electrochemical Toluene sulfonic acid Electrochemical Release 
(Dexamethasone) 
±0.6 V vs 
Ag/AgCl at 0.5 
Hz in PBS 
NIR laser 
(808nm) 
[280] 
Film Electrochemical sodium 
dodecylbenzenesulfonat
e 
Electrochemical Release 
(Biotin) 
±3.0V vs Pt 
wire mesh at 
0.003 Hz 
[259] 
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Film Electrochemical toluene-4-sulfonic acid Electrochemical Release 
(Heparin) 
0 to 3.5 mA 
were applied 
and the heparin 
release was 
monitored for 
120 min 
[281] 
Film Electrochemical para-Toluene sulphonic 
acid 
Electrochemical Release 
( neurotrophin-3) 
± 0.5 mA and ± 
20 mA) at 5 Hz 
[282] 
Sphere Chemical Cl- Electrochemical Release 
(fluorescein, daunorubicin) 
-4.5 V/cm 
electric field 
[266] 
Granule Aggregate Chemical L-serine 
L-glutamic acid 
Electrochemical Release (amoxicillin) ±5 V were 
applied for 2 
min between the 
two electrodes 
in intervals of 
30 min. 
[283] 
Sphere Chemical None pH Release 
(fluorescein sodium, rhodamine 6G) 
pH change 
between 
physiological 
(7.4) and tumour 
site (6.5) 
[284] 
Sphere 
<10 nm 
Chemical Cl- Passive Release 
(Ketoprofen) 
 [268] 
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1.7 Biocompatibility 
It is important to consider the biocompatibility of all nanomaterials for any application 
that involves interfacing with biological systems. Many factors may influence the 
acceptability of the nanomaterial in question to a living system, including the toxicity, 
dispersity, retention and cell adhesion. The inherent toxicity of nanomaterials remains a 
hotly debated topic, with several studies indicating the size-dependant toxicity of sub 
100nm materials, while others refute these claims. The materials of main interest in this 
thesis (TiO2, Fe3O4, and PPy) differ significantly in their biocompatibility. The 
following factors are generally understood to be important in determining the overall 
biocompatibility of the structure:  
(i) Solubility  
(ii) Radical Oxygen Species Generation 
(iii) Particle size and shape 
(iv) Surface charge  
(v) Retention  
(vi) Cell adhesion  
1.7.1 Solubility 
The stability of the material within the media of interest (usually the bloodstream[285] or 
other extracellular fluids[286]) is a generally an important factor in determining the 
cytotoxicity of various nanomaterials[287]. For example, a study  conducted on flame-
made oxide nanoparticles of similar size and shape (spherical, ca. 10-50nm) concluded 
that a relatively low concentration (ca. 3.75ppm) of slightly soluble iron oxide caused 
significant cell death, while comparable concentration of insoluble titanium oxide and 
silica did not cause any loss of cell viability.[287] This highlights the importance of 
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increasing the chemical stability of the nanostructure surface for slightly soluble 
materials. For example, iron oxide nanoparticles intended for biomedical applications 
are usually coated in either chemically inert SiO2[288] or a polymer such as 
polystyrene.[289]  
On the other hand, PPy is insoluble at in physiological conditions, remaining 
stable up to 14 days[290], although beyond that it may undergo some subtle reduction in 
conductivity[291], likely due to interaction with salts in the system.  
1.7.2 Radical Species Generation  
Although TiO2 is insoluble and does not cause cell death via dissolution, it becomes 
toxic due to the photocatalytic production of reactive oxygen species (ROS) at the 
nanoparticle surface. ROS is considered an exemplary nanotoxicity pathway that is 
known to stimulate inflammation[292] as well as to initiate pro-apoptotic[293] cell 
signalling.  
Upon illumination by light of the correct wavelength, electrons (e-) and holes 
(h+) are generated at the TiO2 surface, which then go on to initiate the formation of 
radical OH∙ and peroxide (H2O2) [37] (see Chapter 2 Section 1.1). Both species are highly 
oxidising and may be thus toxic to cells. Studies to date have concluded that while TiO2 
nanoparticles without light illumination are relatively benign (up to 100ug/mL)[294], 
cytotoxicity is significant upon exposure to UVA and may be attributed directly to the 
radical OH generation.[295]  
Similarly, the presence of PPy may stimulate generation of ROS through innate 
immune responses. Studies have observed that the ROS value may reach 58% at a PPy 
concentration of 500 μgmL−1  and is correlated with peak cell death rates, far exceeding 
that by phagocytosis.[296]  
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Although ROS generation is highly damaging to tissue, it is not entirely a 
disadvantage. For example, it has been observed that when TiO2 is used at tumour sites, 
there is a marked synergistic effect when UV irradiation is used in conjunction with 
targeted delivery of anticancer drugs.[297] However, it is important to note that in such 
circumstances it is vital to have good control over location of nanoparticles only at the 
cancerous sites, to which end the use of an Fe3O4 core and/ or targeting molecules is 
helpful.  
1.7.3 Particle Size and shape 
It has been proposed in recent years that materials that may be chemically inert 
(insoluble) in physiological conditions (such as TiO2, SiO2, even noble metals[298]) may 
become toxic when their size is small enough for biological interaction[299]. However, 
there is currently a lack of consensus in the literature to date on the origins of this effect, 
if it is indeed true, and what the crucial cut-off sizes are for various materials. For 
example, while size matters for most metal oxides, with nanoparticles being more toxic 
than microscale counterparts, it was conversely observed that microscale TiO2 may be 
more toxic due to the higher photocatytic efficiency of larger, more crystalline particles 
and subsequent increased ROS generation.[300] The same study found that there was no 
difference between micro- and nanoscale Fe2O3 and Fe3O4 particles.[300] This sentiment 
seems to be supported by Warheit at al. who observed no difference between rutile and 
anatase at 10nm compared to 300nm, and furthermore recorded no difference between 
spherical particles and rods.[301]  
1.7.4 Surface Charge 
Additionally, there is emerging evidence that nanoparticle surface charge may be 
important in determining its toxicity via cellular uptake. Cationic, or positive-charged, 
nanoparticles cause more pronounced disruption of the plasma-membrane integrity, 
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stronger mitochondrial and lysosomal damage and a higher number of autophagosomes 
than equivalent anionic particles.[302]  This is a significant consideration for 
functionalised nanoparticles. Although both bare TiO2[303] and Fe3O4[304] are negatively 
charged at physiological pH (7.4), many functionalization strategies result in the 
amination of this surface and thus positively charged carriers.[305] It is noteworthy that 
polypyrrole is usually negatively charged despite its cationic polymer backbone due to 
the presence of anionic dopants.  
Another factor to consider is the influence of the overall particle surface charge 
on the degree of flocculation. It is generally required that nanoparticles are well-
dispersed to avoid forming large structures within the body that may cause clogging of 
vital functions. Flocculation of nanoparticles in solution is strongly dependant on the 
zeta potential. In general, the overall charge magnitude correlates to the degree of 
electrostatic repulsion between the particles. Thus, the higher the zeta potential, the 
greater is the dispersity of the nanoparticles. On the other hand, the closer the zeta 
potential is to zero, the greater is the flocculation. This effect is studied in some detail in 
Chapter 3 and 4.   
1.7.5 Retention  
It is also important to consider the ultimate fate of the nanocarrier, whether it is passed 
through the body or retained at injection sites. In general, it is desirable to design 
‘stealth’ nanocarriers that are not recognised and have minimal interactions with 
biological components outside of the chosen performance. Due to the novelty of the 
field, long term studies on the effect of retained nanoparticles are missing. Given this 
knowledge gap, most studies suggest that a cautionary stance should be taken with a 
view towards promoting clearance of nanoparticles out of the system. The interaction 
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with voracious cells of the mononuclear phagocyte system (MPS) is of key importance. 
Although this forms the basis of drug delivery where cellular uptake of the particles 
themselves are required[306], in other designs this must be avoided if nanoparticles are to 
be cleared from the system after they have performed their function.[307] Here, shape and 
size may play a role that is distinct from their poorly understood effect on toxicity. 
Studies have shown that larger and more anisotropic particles show greater tendency 
towards retention within the organs.[308] This is an important consideration in view of 
the recent surge in interest in rods[309] and fibres[310] over spherical carriers due to the 
additional, unique capabilities of anisotropic structures. In an ideal scenario, the shape-
factor of the nanocarrier should be tuneable, and results towards this are discussed in 
Chapter 4.   
 
1.8 Research Questions  
Given the current state-of-the-art and knowledge gaps identified so far in this chapter, 
this dissertation will focus on the synthesis and optimisation of exogenously stimulated 
structures based on light and magnetoresponsive materials primarily for controlled drug 
release applications. Based on the literature review conducted, of particular interest are 
titania (TiO2), a strong photocatalyst, magnetite (Fe3O4), a superparamagnetic form of 
iron oxide, and polypyrrole (PPy), a photothermal and electrically conductive polymer. 
The photocatalytic response of TiO2 may be used for light-activated molecule release[23] 
as well as redox-assisted treatment of cancer cells.[311] Magnetic nanoparticles are useful 
as they allow for magnetic field targeting[91], MRI imaging[312] and magnetothermal 
therapy[94]. Polypyrrole has been successfully used for electrochemical drug delivery[282] 
and photothermal therapy[313]. 
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In the case of TiO2, there remain some fundamental questions on mechanism of 
the apparent photocatalytic release reported by some authors to date. There remains 
some disagreement on the fate of the adsorbed functional molecules upon irradiation 
with UV light and subsequent electron/hole generation. It is currently unclear whether 
the functional molecule degrades due to photcatalysis at the TiO2 surface, or if 
photocatalysis simply results in the photocleavage of TiO2-functional molecules instead. 
Both have been reported in literature to date. Distinction between the two is of vital 
importance in drug delivery applications for two reasons. Firstly, it is important to 
preserve the whole, undamaged structure of the pharmaceuticals that have been released 
in order to maintain efficacy. Secondly, it is important to minimise the evolution of side 
products that may have unknown impact on the biological environment. 
The functionalisation of TiO2, Fe3O4 and PPy is an active field with many 
strategies currently in use. Amino acids are the focus due to their high biocompatibility 
and proven ability to delivery useful moieties such as DNA[210], proteins[314] and 
prodrugs[315]. Additionally, the amphoteric nature of amino acids leads to ambiguous 
interaction with the nanomaterials in question. For example, they can bind by either –
COOH or –NH2 groups of the amino acid, with a current lack of unified study over the 
effect of various reaction parameters on this binding mode. In the case of PPy, it is 
known that the material can only be doped with anionic functional molecules. Yet, there 
is a lack of systematic study on inclusion of amino acids under variable reaction pH. 
These questions do not currently have solutions and would benefit from a thorough 
investigation. 
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To summarise, the following key qeustions form the basis of this thesis:  
1. What is the mode of apparently reported TiO2 photocatalytic drug release?   
2. What is the impact of reaction parameters, particularly pH, on amino acid 
binding to various metal oxide nanoparticles?  
3. How can the configuration of the above be optimised for delivery of desired 
moieties? 
4. What is the effect of amino acid functionalisation on the flocculation of the 
nanoparticles?  
5. What is the subsequent effect of this flocculation on the usefulness of the 
structure? 
These fundamental questions have not yet been adequately addressed in the literature. 
Therefore, their investigation constitutes a novel and valuable contribution to the field.  
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Published with modifications:  
Zhang, T., M. A. Go, et al. (2015). "Low-cost photo-responsive nanocarriers by one-
step functionalization of flame-made titania agglomerates with L-Lysine." Journal of 
Materials Chemistry B 3(8): 1677-1687. 
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Chapter Overview 
This chapter covers the synthesis of flame-made metal oxides (SiO2, TiO2 and iron 
oxides) and their subsequent functionalisation with the amino acids L-lysine and L-
glutamic acid. In particular, it focusses on the effect that the reaction pH has on the 
resulting zeta potential, particle flocculation / self-assembly and reactive amine content 
as indicated by an amine-reactive fluorescent label. Furthermore, for TiO2, an important 
photocatalyst, the time-dependant release of the surface-bound functional molecules 
under exposure to UVA light is shown. The release of the bound amino acid is shown to 
be crucially time-dependant, with the onset of a photocatalytic decomposition via a 
cyclisation pathway occurring after ca. 10s. A model drug, the anti-inflammatory 
ketoprofen, is then loaded to the active -NH2 of the material. It is shown that in such 
circumstances the photocatalysis breaks the bond between the amino acid tether and the 
loaded pharmaceutical, releasing the drug as an unmodified molecule, demonstrating the 
usefulness of this nanocarrier for the light-triggered delivery of biologically important 
and highly specific compounds. A schematic of the overall functionalisation – release 
process is provided in figure 24.  
 
Figure 24. Chapter three overview. (a) FSP-synthesis of metal oxide nanoparticles. (b) Functionalisation 
using amino acids at different pH resulting in different coating morphology. (c) Exploiting –NH2 
termination for attachment of FITC dye or ketoprofen. (d) Exposure of photocatalytic TiO2 to UV light 
for release of the functional molecules.  
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2.1 Introduction 
Metal oxide based nanomaterials have recently gained much interest in the field of drug 
release for both passive and active/ selective release systems, as previously discussed in 
Chapter One. TiO2 is popular in this field due to its photocatalytic properties that allow 
for light-triggered, controlled release[16], while Fe3O4 contributes useful 
superparamagnetic properties[90] and SiO2 is ubiquitous in applications that required 
chemically inert biomedical coating[81] or passive porous carriers[79]. These three 
materials demonstrate currently ambiguous amino acid adsorption, despite their prolific 
use in the field, and poses one of the fundamental research questions of this thesis. 
Therefore, this chapter aims to investigate the role of pH on the adsorption of amino 
acids on TiO2, SiO2 and Fe3O4 surfaces and optimise with respect to loading of –NH2 
reactive deliverable molecules.  
2.1 Synthesis of MOx nanoparticles and their material properties 
Nanoparticles were synthesised using flame-spray pyrolysis due to the high yield of 
crystalline, pure nanoparticles in the size range 5-50nm produced by this method.  
Both SiO2 and TiO2 were produced at previously established standard reaction 
conditions for the flame reactor (5 bar nozzle pressure, 5mL/min precursor feed rate, 
5L/min dispersion oxygen). Micrographs showing the typical products obtained are 
shown in Figure 25. The SiO2 was amorphous with dTEM ca. 10nm , consistent with 
previous reports[316]. TiO2 produced was ca. 20nm with a facetted shape that is also 
consistent expectations.  
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Figure 25. TEM showing (a) SiO2 and (b) TiO2 NPs synthesised at 5/5/5 flame conditions. 
 
XRD was performed to determine the crystal structure of TiO2 (Figure 26 a) and 
revealed a predominantly anatase phase (A, between 87.1% and 80.0%) with a small 
content of rutile (R, between 12.9% and 20.0%). Due to the higher photocatalytic 
activity of anatase relative to that of rutile[317], it is advantageous to have of a higher 
content of anatase. It has also been suggested that a mixture of anatase and rutile that 
typically results from flame-spray pyrolysis routes may in fact have an enhanced 
photocatalytic efficiency compared to pure anatase alone. This is due to a synergistic 
interaction with the rutile phase, with a reported optimal content of ca. 39mol% anatase 
identified for water splitting efficiency.[318] However, here, phase composition was not 
optimised further as this is outside the primary aims of this dissertation. 
The nanoparticle band gap was obtained from the UV-vis absorbance spectrum 
(Figure 26 b) as approximately 390 – 400 nm (3.2 eV) using the Tauc plot method and 
comparable to previously reported values for flame-made TiO2 of similar size.[319] 
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Figure 26.  (a) XRD Spectrum of flame-made TiO2 nanoparticles showing Anatase (A) and Rutile (R) 
phases. (b) Optical absorbance of TiO2  and (c) Tauc plot showing bandgap at ca. 390nm.  
 
Due to the range of iron oxides compositions that are possible via flame-spray 
pyrolysis, the synthesis parameters were altered systematically in an attempt to optimise 
the resulting product’s composition and magnetic properties. It was found that the flame 
reactor was highly sensitive towards the synthesis conditions, in particular the nozzle 
pressure drop, and would produce clean combustion only at 5bar ±1 bar. Outside of this 
pressure, poor atomization was observed during combustion and, and in some cases a 
black residue was formed that is characteristic of incomplete combustion. Therefore, the 
pressure was fixed at 5 bar while the governing parameter [Fe]/O2 [mol/L][172] was 
changed by altering the dispersion oxygen and feed rates.  
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It was discovered that the overall nanoparticle size (dBET) was directly 
proportional to the [Fe]/O2 mol/L concentration in the system at a constant 5 bar 
pressure (Figure 27). 
 
Figure 27. Particle size of FSP-made iron oxide nanoparticles as a function of [Fe]/O2 (mol/L) at constant 
5bar pressure. 
 
It is usually desirable to reduce the size of the nanoparticle as it is their small 
size that is advantageous in many applications. Based on these results, a smaller [Fe]/O2 
ratio is favourable in this respect. However, in the case of iron oxides, optimisation of 
the product must also take into account the phase composition(s) produced across the 
reaction parameters as the phase of the iron oxide together with the size determines its 
magnetic properties. It was found that the nanoparticles produced were mixtures of 
hematite and magnetite (Figure 28, Figure 29) and is consistent with previous reports. 
To date, mixtures of hematite, maghemite[177], magnetite[177] and wustite[177] have been 
reported for iron oxides produced by the FSP method. Due to the desirable 
superparamagnetic properties of magnetite (Fe3O4) over the other phases of iron oxides, 
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the synthesis was optimised with a view to maximising the content of Fe3O4. It was 
discovered that the optimal conditions to produce Fe3O4 were 6 mol/L [Fe2+] precursor 
concentration, 5L/min dispersion oxygen, 5 bar oxygen pressure, producing a 
nanoparticle of ca. 20nm size (dBET = 20nm, dTEM = 17nm) that is ca. 98% Fe3O4 / 2% 
Fe2O3 (Figure 28, Green line).  
 
Figure 28. XRD spectra of FSP-made iron oxide NPs as a function of [Fe]/O2 at constant 5 bar pressure.  
 
Figure 29. Magnetite weight content of FSP made iron oxide NPs as a function of [Fe]/O2 at constant 5 
bar pressure.  
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Finally, the magnetic properties of the flame-made iron oxides were assessed by 
magnetic hysteresis and compared against a commercially available Fe3O4. These 
results were in good agreement with the phase composition data obtained by XRD, 
showing a maximum saturation magnetisation for the sample that contained the highest 
magnetite content (Figure 30, green line). However, this value was still approximately 
50% lower than that of the commercial Fe3O4 (Figure 30, black line). This can be 
attributed to the difference in the nanoparticle size. The commercial magnetite has a 
reported size of ca. 50nm, while the flame-made is ca. 30nm. This is consistent with the 
expect increase in magnetisation as the particle size increases.[320] Additionally, the 
crystallinity is expected to differ between the products. The flame-made nanoparticles 
had a quasi-spherical shape with slight faceting compared with the highly geometrical 
cubic shape of the commercial product. The TEM and size distributions of typical 
commercial and flame-made iron oxides are included in Figure 31. A high 
magnetisation is generally an advantage as it implies the ability to induce a stronger 
magnetic field with the material (and from there, stronger secondary responses for 
magnetic motion, or magnetotherapy) requiring a weaker externally applied field. 
 However, this desirable quality should always be balanced by other properties. 
One is the particle size, always important in drug release, and another is the remanence 
and coercivity of the material. Truly superparamagnetic materials have a remanence and 
coercivity close to 0, meaning that they lose all magnetisation upon removal of the 
external source. This is important as it is typically not desirable to have nanoparticles 
that behave as weak ferromagnets after the external field is switched off. For example, 
they may experience attractions leading to flocculation and formation of large structures 
that may obstruct blood vessels or otherwise be disruptive. The remanence values were 
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tabulated alongside the magnetisation at 1T (Table 8) for each product synthesised 
alongside commercial magnetite.  
 
 
Figure 30. Magnetic hysteresis of flame-made iron oxides at various [Fe]/O2 concentration and fixed 5bar 
pressure drop (coloured lines), compared against commercial Fe3O4 NPs (black line). 
 
Table 8 Remanence and magnetisation at 1T for flame-made and commercial magnetite. 
[Fe]/O2 (mol/L) % Fe3O4 Size (nm) Magnetisation at 1T 
(emu/g) 
Remanence (emu/g) 
0.0003 92.5 13 14.20 0.784 
0.0004 88 19 15.19 0.957 
0.0005 68 15 13.71 0.739 
0.0006 71 18 12.88 1.09 
0.0009 98 28 40.98 3.77 
Commercial 
Magnetite 
100 50-80nm 89.27 9.41 
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Figure 31. TEM and size distributions for (a) flame-made at [Fe]/O2 = 0.0003 mol/L, (b) flame-made at 
[Fe]/O2 = 0.0009 mol/L, and (c) commercial iron oxides.  
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2.2 Adsorption of amino acids  
SiO2, TiO2 and Fe3O4 (flame-made at [Fe]/O2 = 0.0009 mol/L) nanoparticles were then 
used for the adsorption of amino acids from aqueous media under variable pH. The 
amino acids used for these experiments were L-glutamic acid and L-lysine, chosen for 
their importance for further biomedical applications as well as their contrasting acid-
base character (L-lysine being a basic type and L-glutamic acid being an acidic type). 
Three pHs were investigated: pH 7 (water), pH 10 (adjusted by the addition of NaOH) 
and pH 2 (adjusted by the addition of HCl).  
The zeta potential was recorded between the bare nanoparticles suspended in 
water and those with adsorbed amino acid(s). Table 9 shows the zeta potentials in water 
measured for the flame-made nanoparticles used in this thesis. TiO2, the most important 
material in this study, was further titrated, and its isoelectric point was identified as 3.5 
(See Appendices) Upon adsorption of amino acids, the measured zeta potential changed 
significantly due to the contribution of the charged -NH3+/-COO- groups towards the 
surface charge of the functionalized nanoparticle. Depending on which group(s) are 
involved in the binding of the molecule at the nanoparticle surface and which groups are 
left exposed, the charge state of the overall structure is expected to differ. For example, 
in the case of L-lysine, expressed in –(α)-NH3+/(γ)-NH3+/-COO- at pH 7, if –COO- is 
involved in the amino acid adsorption, the remaining (α)-NH3+/(γ)-NH3+are expected to 
contribute a positive charge to the structure, and vice versa.  
The adsorption of amino acids onto the nanoparticle surface is also expected to 
have a significant effect on the flocculation dynamics of the system. This is due to the 
strong effects of electrostatic attraction and repulsion. For example, two neighbouring 
highly charged nanoparticles will repel one another. On the other hands, there is the 
potential of strong attraction between the neighbouring –NH3+/-COO- groups of amino 
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acids giving rise to the potential of agglomeration via electrostatically stacked 
nanoparticles. Thus, the changes in the hydrodynamic diameter were recorded alongside 
zeta potential for all samples. Initially, adsorption from water (pH 7) was studied for all 
three nanoparticles (Table 9). 
  
Table 9. Evolution in zeta potential and hydrodynamic diameter of metal oxide nanoparticles after 
adsorption of L-lysine from aqueous (pH 7) solution. 
 As Prepared MOx NPs Lysine-MOx 
pH 7 (water) 
 Zeta Potential 
(mV) 
Hydrodynamic 
Diameter (nm) 
Zeta Potential 
(mV) 
Hydrodynamic 
Diameter (nm) 
SiO2 -22.6 mV 160 nm -3.8 mV 3181 nm 
Fe3O4 -27.5 mV 226.5 nm +14.7 mV 1324 nm 
TiO2 -25 mV 180 nm +9.0mV 2000 nm 
  
Several observations come from these results. Firstly, it is worth noting that the 
hydrodynamic diameter increases drastically generally from ca. 150-200nm by a factor 
of approximately 10 to ca. 1500-3000 nm. This suggests that the adsorption of L-lysine 
does indeed increase the flocculation dynamics of the system, consistent with existing 
theories.[321] This also suggests that adsorbed amino acids may indeed be used to 
assemble the nanoparticles into larger, more complex structures via the electrostatic 
interactions between activated -NH3+ and -COO- of neighbouring amino acids that act as 
bridges between the attached nanoparticles.  
This phenomenon is later exploited (see Chapter Three) to direct the assembly 
of iron oxide anisotropic structures. However, this tendency to associate into larger 
structures needs to be monitored/controlled as the small size of nanoparticles is one of 
their most desirable features of nanoscale loading and release systems. The small size 
scale allows for their movement away from their injection / implant point, for example, 
and their subsequent diffusion through biological system. The small size of nanoscale 
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materials also gives rise to the large surface that define their difference from their bulk 
counterparts. In this application, the high surface area offered by small particle sizes 
serves as the high capacity platform for the loading and release of functional molecules. 
The formation of large, densely assembled structures is a detriment in both aspects.  
It should be noted that over the same reaction conditions (24 hours, pH 7), the 
degree of functionalisation as assessed by the positive shift in the zeta potential is not 
equal between the three metal oxide nanoparticles studied. It is apparent that Fe3O4 
nanoparticles arrive at the highest positive potential followed by TiO2 and finally SiO2. 
This shift is related not only to the overall concentration of positive-contributing L-
lysine molecules adsorbed, but is also suggestive of the preferred adsorption orientation 
of the amino acid. It can be expected that the positively charged products (Lys-Fe3O4, 
Lys-TiO2) should contain a higher surface coverage of free, reactive amine groups 
compared with the negatively charge product (Lys-SiO2). This is largely consistent with 
literature. Although the interaction between amino acids and TiO2 and SiO2 surfaces is 
ongoing,[322] the adsorption of -COOH groups onto iron oxides is currently well-
established.[323] 
With respect to subsequent binding of proteins, viral vectors and formation of 
useful prodrugs, it is generally advantageous to promote higher available, reactive 
amine content[324]. Thus, experiments were performed to determine the effect of pH and 
amino acid concentration on the charge state of AA-functionalized TiO2 to optimise this 
material for subsequent reaction steps. For L-lysine, it was clear that the reaction pH has 
a significant effect on the overall zeta potential and hydrodynamic diameter (Figure 32). 
In particular, we note that acidic conditions favour the adsorption of L-lysine to form 
positively charged, relatively colloidally stable structures. This is line with studies that 
show that adsorption of carboxylates is preferred under acidic conditions[325].  
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Figure 32. Evolution of (a) zeta potential and (b) hydrodynamic diameter of unmodified TiO2 (black 
circles) and lysine-functionalised TiO2 synthesised at acidic (red circles), neutral (green circles) and 
alkaline (blue circles).  
 
As before, the hydrodynamic diameter trends inversely with the overall 
magnitude of the zeta potential, illustrating the key role of electrostatic repulsion in the 
stability of colloidal nanoparticle suspensions. Additionally, the pH of the lysine 
adsorption has a significant effect on the morphology of the flocculated agglomerates. 
Transmission Electron Microscopy was performed (Figure 33) and the resulting images 
show a significant difference on the fractal dimension of the amino-acid functionalized 
products. When lysine is adsorbed from acidic (pH 1.5) solution, the agglomerates, 
while possessing a higher hydrodynamic diameter, retain the same open fractal structure 
as the as-prepared nanoparticles. This open structure is consistent with the reversibly 
agglomerated structure that results from random collision of the nanoparticles within a 
solution.  
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Figure 33. TEM micrographs showing the agglomerate size and morphology of (a) as-prepared and 
lysine-functionalized TiO2 nanoparticles at (b) pH 1.5 and (c) 9. 
 
Figure 34. FTIR of bare TiO2 (red), lysine-functionalized TiO2 nanoparticles at pH 1.5 (blue), pH 9 
(pink) and pure L-lysine powder (black). 
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However, when the lysine is adsorbed from an alkaline solution, the results are 
markedly different. Now, the agglomerates are not only larger but also show a denser 
structure. At higher magnification, it is possible to see an amorphous layer. This is 
consistent with the condensation of multiple layers of lysine molecules upon the 
nanoparticle surface that can be expected at pH 9 due to the zwitterionic form of the 
amino acid allowing for electrostatic attraction of neighbouring molecules. The 
increased agglomerate size and dense structure is indicative of the assembly of the 
nanoparticles into larger, microscale structures that is promoted by the adsorption of 
zwitterionic amino acids. In fact, lysine electrostatic attractions have been used by other 
researchers to form of relatively stable composites of 700 to 1200 nm[326] 
This pH-dependant functionalisation/ coating is further supported by the FTIR 
results. The as-prepared TiO2 (Figure 34, red line) spectrum was characterized by strong 
absorption bands below 850 cm-1. These are attributed to the lattice vibrations of 
TiO2[327], and confirm the high crystallinity of the flame-made samples. The spectrum of 
the acidic conjugated samples (Figure 34, blue line) was similar to that of the as-
prepared TiO2 showing few peaks matching the lysine spectrum (Figure 34, black line). 
This further supports the successful formation of an adsorbed lysine layer as indicated 
by the changes in zeta potential.  
Conjugation in alkaline conditions (Figure 34, pink line) resulted in significantly 
higher match to the lysine spectrum (Figure 34, black line) with a similar broad hump 
between 3600-2000 cm-1 appearing. This is characteristic of solid lysine samples dried 
upon reactions in highly alkaline conditions (pH ~12)[328] and it is commonly attributed 
to the overlapping bands of NH+ groups[329]. Here, this NH+ surge is attributed to the 
formation of disordered, dendritic lysine mass terminating in protonated amino groups. 
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The sharp peaks at 2922 cm-1 and 2850 cm-1 are assigned to CH2 bonds[328]. Their 
intensity increases rapidly with the mass of lysine molecules surrounding the 
nanoparticles.  
The effect of pH is even more remarkable for the adsorption of L-glutamic acid 
onto TiO2 (Table 10). Here, we see that at under alkaline conditions the zeta potential is 
unmodified (ca. -40mV), suggesting insignificant adsorption of the amino acid, while 
under acidic conditions the zeta potential shifts significantly towards +38.4mV. This is 
in keeping with the –COOH dominant adsorption hypothesis under acidic conditions. 
Due to glutamic acid possessing two –COOH groups, it is within reason that its 
adsorption can be drastically promoted by acidifying the reaction media. Furthermore, 
we note that theoretical modelling indicates that dicarboxylic acids may adsorb strongly 
via the bidentate bridging and chelating formations available to these molecules. [330] In 
such situations, the bidentate-adsorbed molecule may be expected to contribute even 
more strongly towards the positive shift in the zeta potential due to the single residual –
NH3+ group being exposed. 
 
Table 10. Evolution of zeta potential and hydrodynamic diameter between pure TiO2 and lysine-
functionalized TiO2 
 Bare TiO2 Glut-TiO2 pH 1.5 Glut-TiO2 pH 9 
Zeta Potential (mV) -40.0 +38.4 -40.2 
 
2.3 Activity of –NH2 termination 
Since subsequent attachment of proteins and DNA vectors are amine-reactive, it was 
necessary to directly gauge the reactivity of the amines on the functionalised 
nanoparticles. This was done by reaction with fluorescein isothiocyanate (FITC), a 
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fluorescent, primary amine-reactive dye, to create fluorescent-labelled nanoparticles 
with a characteristic FITC absorbance at ca. 470nm.  
This experiment was performed on the lysine-TiO2 previously synthesised from 
alkaline and acidic conditions. An as-prepared TiO2 was subjected to the same FITC 
treatment as a control against the possibility of direct adsorption of FITC onto TiO2. A 
higher concentration of FITC was detected for the acidic lysine functionalisation than 
the alkaline counterpart (Figure 35), suggesting greater availability of –NH3 
terminations and is consist with previous zeta potential measurements. 
 Following from this, further experiments were conducted to try and optimise the 
dye loading further as loading capacity is a crucial metric for performance as a 
nanocarrier. Since previous experiments used excess quantities of L-lysine that resulted 
in the formation of a large, encapsulating mass of organic matter around the 
nanoparticles, an attempt was made to decrease the concentration. Using theoretical 
models of the available binding site concentrations on TiO2 surfaces, a concentration 
corresponding to a single monolayer of adsorbed L-lysine molecules was formulated 
and the experiments repeated for both acidic (pH 1.5) and alkaline (pH 9) lysine 
adsorption, followed by FITC labelling of free –NH2. This was found to have a 
significant effect on the loading capacity of the carrier towards the dye (Figure 35, b), 
increasing by a factor of 10. Once again, the reaction pH had a significant effect, with a 
lower pH preferred. The final –NH2 availability for the lower concentration was further 
studied across reaction time.  
The measured FITC concentration was computed as a ratio over the theoretical 
number of surface Ti-binding sites to help visualise the functional molecule density 
(Figure 36). The theoretical Ti-sites were estimated from the surface density of Ti atoms 
using the average particle size, assuming a spherical geometry and (101) and (110) 
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surfaces planes for anatase and rutile respectively (see Materials and Methods for more 
information). This ratio was found to peak at 3 hours, after which a gradual decline was 
recorded. It is hypothesised that this peak represents the maximum adsorption of 
reactive L-lysine onto the TiO2 surface before the organics begins to degrade due to the 
imperfect blockage of ambient light during the total reaction time.  
 
Figure 35. (a) Absorbance spectra of FITC conjugated onto bare TiO2 (black), and lysine-TiO2 prepared 
with excess L-lysine at pH 1.5 (pink) and pH 9 (blue). (b) Absorbance spectra of FITC conjugated onto 
lysine-TiO2 prepared with low concentration of L-lysine at pH 1.5 (red) and pH 9 (blue)  
 
 
Figure 36. nFITC/ Surface Ti-binding site ratio computed for lysine-TiO2 at low concentration pH 1.5 
across a long term study.  
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2.4 Response of AA-functionalised TiO2 nanoparticles towards UV light 
Having established an optimal condition for the amino-functionalization of the TiO2 
nanoparticles, the photocatalytic response of the material was then determined. The 
lysine-coated samples were exposed for variable time intervals to UV light. In general, a 
decrease in the recorded hydrodynamic diameter (Figure 37 b) was recorded alongside a 
negative shift in the zeta potential (Figure 37 a) towards the original value for the bare 
TiO2. Upon 20 s exposure, the DLS agglomerate size distribution (Figure 38) of the low 
concentration lysine-TiO2 shifted from a large agglomerated distribution back to a 
unimodal that is similar to that of the as-prepared powders. In line with these results, 
their ζ-potential (Figure 37 a) decreased from ca. -12 mV of the acidic conjugated 
samples back to -35 ± 1 mV, close to that (-40 mV) of the as-prepared TiO2. Analysis of 
the photo-response dynamics (Figure 37 b) indicated an asymptotic decrease in 
hydrodynamic diameter (dH) within the first 30 s of UV exposure with dH decreasing 
from 1100 nm of the 0.5 ML (tr = 120h) acidic conjugated samples to ca. 400 nm. Both 
behaviours are consistent with the successive removal of lysine molecules from the 
nanoparticle surface.  
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Figure 37. (a) Zeta potential and (b) hydrodynamic diameter of lys-TiO2 after increasing exposure to UV-
A light. 
 
 
Figure 38. hydrodynamic diameter distribution of lys-TiO2 before (black line) and after 30s (blue line) 
exposure to UV-A light.  
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Although promising, these results alone cannot confirm that the nanocarrier is 
responding to the applied UV light by releasing the surface-adsorbed molecules. 
Instead, it is possible that the molecules are simply being destroyed by photocatalytic 
redox events on the surface, thus returning the nanoparticle to its initial, unmodified 
properties. The decomposition of various amino acids solution by photocatalysis of 
TiO2 is well-known.[218] Therefore, the lysine content liberated into solution after UV 
exposure was confirmed by using a Fluorescamine reaction on the solution after 
removal of the particles post-UV treatment in order to assess the release rate in greater 
detail.  Fluorescamine reacts with primary amines to create a fluorescent adduct (Figure 
39) that can be correlated to lysine concentration with appropriate calibration (see 
Appendices). In this way, an estimate on the free lysine concentration as a function of 
the UV exposure time was obtained.  
 
Figure 39. (a) Reaction between primary amine and fluorescamine producing a fluorescent adduct. (b) 
Fluorescamine assay of free lysine concentration in solution after exposure to UV light.  
 
a b 
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The result obtained is interesting as a peak was recorded at 10s rather than a 
sustained increase reaching a final asymptotic value as might be expected from a 
continuous activation. The two pathways that may be imagined are readsorption 
(unlikely, considering the consistent return of zeta potential and hydrodynamic diameter 
towards original values), or the loss of reactive -NH2 via redox events. This may be 
attributed to the subsequent photocatalytic degradation of amino acids via redox events 
in accordance with known pathways[331] that may begin after this time. For example, it 
is been observed that photocatalysis of lysine on TiO2 may cause selective cyclisation 
into pipecolinic acid[332] via the following reaction pathway (Figure 40).  
 
Figure 40.Photocatalytic cyclization of lysine into pipecolinic acid isomers. Adapted from [333] 
 
To test this hypothesis, GC-MS was performed on the particle-free solutions. A 
strong match for L-lysine (Figure 41 a) was obtained, but evolution of pipecolinic acid 
was detected simultaneously (Figure 41 b), suggesting that photocatalysed conversion 
of lysine to its cyclisation compound[334] does occur in solution, in line with 
literature[335]. This result highlights the importance of controlling the UV exposure time 
in such a system as although the molecule release from the carrier surface scales with 
exposure time, there exists a critical point at which photocatalytic degradation appears 
to take over. In this particular case, photo-degradation of the functional molecule 
becomes dominant by ca. 10s.  
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Figure 41. Mass spectrometry of particle-free solution after successive UV illumination showing (a,b) L-
lysine and (c,d) pipecolinic acid, its radical cyclisation product. 
 
For comparison, glutamic acid an analogous study was conducted on L-glutamic 
acid. Following the insights from L-lysine functionalization strategies, this was 
performed using calculated monolayer coverage of L-glutamic acid in acidic conditions 
at a nominal reaction time of 24 hours (the full optimisation over the reaction time 
parameter not being carried out for this molecule). This functionalised material was then 
exposed to successive UV and the particle-free solution assayed with fluorescamine as 
per previous experiments (Figure 42). A similar trend was observed for glutamate, 
consisting of a maximum concentration released at ca. 5s followed by a gradual 
a 
c 
b 
d 
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decrease. Mass spectrometry confirmed that glutamate’s cyclisation product, 
pyroglutamic acid, was simultaneously formed (Figure 43), suggesting an analogous 
mechanism. However, it should be noted that in this case the quantitation of the mass 
spectra data does not fully agree with that obtained by the fluorescamine assay. While 
ca. 5s appears to be the peak time for glutamate release according to the fluorescamine 
assay, the mass spectra seem to indicate that 10s is preferable, as for the L-lysine 
release. It should be noted that the time point at 5s for the fluorescamine assay is highly 
variable and this may account for the oscillatory shape of the glutamic acid peak 
intensity recorded by mass spec at 5s (Fig. 43 c).  
 
Figure 42. Fluorescamine assay of particle-free solution for glutamate-TiO2 after exposure to UV.  
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Figure 43. (a) Mass spectrometry results for particle-free solution after exposing glutamate-TiO2 to UV 
light showing evolution of (b,c) free glutamate alongside (d,e) pyroglutamic acid.  
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2.5 Loading and release of model drugs 
Next, the amine groups of the lysine-TiO2 were conjugated with a model drug, the anti-
inflammatory ketoprofen (Figure 44 a). This is a useful model as the attachment of 
ketoprofen to L-lysine can improve the uptake of the drug through the blood-brain-
barrier (BBB). Ketoprofen being ordinarily hydrophilic cannot easily cross the BBB 
unless attached to a nanocarrier[336] or modified by amino acids to allow for transport 
across the large amino acid transporters[337]. Thereafter biodegradation of the lysine-
ketoprofen link yields pharmacologically active ketoprofen.[337] Thus, the release of the 
full prodrug (Ketoprofen-Lysine) from a nanocarrier is of importance, and is currently 
not well-studied. It is not yet fully understood, for example, where the bond(s) will 
break in a system comprising ketoprofen-lysine-TiO2 and thus whether the prodrug, the 
drug, or some partially photocatalytically degraded intermediate will be released, 
although this question is a crucial one.  
Mass spectrometry was performed on the free solution to identify products 
present after progressive UV light exposure. and identified a strong match for 
ketoprofen (Figure 44 b). Although 10s was previously established as ideal for lysine 
release, it was found that the ketoprofen-lysine pro-drug concentration at 5s UV 
illumination after which point the signal decreased again (Figure 44 c),  
It is of interest to note that the m/z values were a close match to ketoprofen 
(Figure 44 b) and no evidence of the ketoprofen-lysine pro-drug structure[35] was 
recorded. At the same time, no signatures corresponding with L-lysine (Figure 44 e) or 
the cyclization product pipecolinic acid (Figure 44 f) were recorded. Based on these 
data, it is proposed that UV-triggered release is causing a rupture of the ketoprofen-
lysine bond (Figure 44 g). This result is significant as it implies that photocatalytic drug 
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release systems based on amino acid-functionalised TiO2 cannot be used to successfully 
deliver amino acid-modified prodrugs as the electron-hole generation events cascade to 
cause detachment of the amino acid from the end-loaded drug molecule.  
On the other hand, this result may also mean that highly specific molecules that 
cannot be afforded irreversible covalent modification may be successfully delivered as 
it appears that the bond between the payload molecule and the amino acid tether is 
detached during the light-activated release process. This is an important observation that 
has not been previously reported as far as the author is aware. 
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Figure 44. (a) Reaction pathway to synthesise ketoprofen-lysine prodrug.[337] (b, c,d) mass spectrometry 
results showing release of ketoprofen and absence of (e)L-lysine and (f) pipecolinic acid peaks. 
 
a 
b 
c d 
e f 
91 
 
Chapter Two – Optimising Amino Acid Functionalisation 
 
Chapter Summary 
In this chapter, biomedically important metal oxide nanoparticles SiO2, TiO2 and Fe3O4 
were synthesised by flame-spray pyrolysis and their material properties characterised. 
An optimisation of Fe3O4 synthesis for magnetic properties and particle size was 
presented. A general strategy was devised for the functionalisation of these materials 
with amino acids L-lysine and L-glutamic acid. An optimisation strategy based on 
altering the reaction pH, amino acid concentration and reaction time was developed. 
The initial hypothesis that the reaction pH will have significant effects on the overall 
reactivity and flocculation dynamics of the nanocomposites was proven to be correct. In 
particular, it was discovered that: (i) acidic conditions result in greater extent of binding 
by –COOH groups, leaving greater content of –NH2 terminations free for further 
reactions, (ii) amino acids can induce electrostatic flocculation and assembly of large, 
micro-scale aggregate when functionalisation is carried out in alkaline conditions, (iii) 
to limit flocculation and maximise available –NH2, amino acid concentration and 
reaction time should be controlled.  
The photocatalytic response of functionalised TiO2 towards UV light was 
investigated, and a mechanism comprising simultaneous cleavage of the lysine-TiO2 
bonds and radical degradation of the functional molecule into its cyclisation compound 
Pipecolinic acid was proposed based on mass spectrometry and Fluorescamine assay 
results. An optimal time for the release of the amino acid before photocatalytic 
decomposition was identified at ca. 10s. Finally, a model drug Ketoprofen was 
successfully loaded and released by short term exposure of the composite to UV light. 
Despite the covalent attachment of the ketoprofen to the lysine molecule, forming a 
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lysine-ketoprofen prodrug, upon illumination by UV light, free ketoprofen alone was 
detected in the solution, suggesting that the photocatalytic action caused a cleavage of 
the bond between the amino acid and the loaded drug in this instance.  
Overall, it was discovered that UV light could successfully and controllably 
trigger the release of a bound drug in a time range that is that significantly shorter than 
that reported in literature. To date, the majority of TiO2 drug delivery systems do not 
make use of the photocatalytic effect and as a result still report a cumulative release that 
requires hours or even days to reach a maximum value.[67] The system developed here 
has an action time that is competitive with that reported by the few other photocatalytic 
TiO2 drug release systems that currently exist. For example, by Shrestha et al. were able 
to release a model dye in “a few seconds” from an array of nanotubes, although they 
were unable to quantify the release and extend this to a useful drug. [16] Song et al. were 
able to release a bound enzyme, although over a significantly longer 600s.[31] As far as 
the author is aware, this is the first time that the decay in the detected level of the 
released compound has been reported alongside the evolution of redox decomposition 
products. 
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2.6 Materials and Methods  
Flame synthesis of TiO2 agglomerates  
A flame spray pyrolysis (FSP) reactor was used for the synthesis of TiO2 nanoparticles. 
The liquid precursor was prepared by diluting 0.5 mol/L of titanium(IV) isopropoxide 
(TTIP, Aldrich, purity > 97%) in xylene (Fluka, purity > 98.5%). The solution was 
supplied at a rate of 5 ml/min through the FSP nozzle and dispersed to a fine spray with 
5 l min1 oxygen (pressure drop 6 bar) through the surrounding annulus. This spray was 
ignited by a supporting annular ring of premixed methane/oxygen flamelets (CH4 ¼ 1.2 
L/min and O2 ¼ 2 L/min ). Powder samples were collected with a vacuum pump 
(ICME Type M80B4) on water-cooled glass fibre filters (Sartorius glass microfiber FT-
3-01124- 150, 160 mm diameter) placed at ca. 40 cm height above the burner. X-ray 
diffraction analysis was performed with a Bruker, D2 Phaser diffractometer operated at 
30 kV, 10 mA at 2q (Cu Kα), range 10–80θ, step size 0.2θ and scan speed 2.3θ / min. 
The crystal size (dXRD) was determined by Rietveld analysis with the structural 
parameters of rutile and anatase. The powder specific surface area (SSA) was measured 
by BET analysis using a Micromeritics Tristar II. BET equivalent diameter was 
calculated for spherical primary particles using the XRD weighted average densities of 
TiO2 rutile and anatase. Transmission electron microscopy was conducted using a 
Hitachi H2100, operated at 125 kV.  
Amino acid functionalisation  
Functionalisation was carried out in aqueous solutions at pH 9, pH 7 and pH 1.5 
prepared by adding HCl (Aldrich, purity > 37%) and NaOH (Aldrich, purity > 97%) to 
distilled water. The pH was measured using a pH probe (Oakton pH 700) at the start of 
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the reaction. The TiO2 powders were first calcined in a muffle furnace (CEMMS) for 4 
h at 450 C to desorb physi- or chemisorbed H2O. Then, 9 ml of 5.23 mmol/L TiO2 
nanoparticle suspensions were prepared by adding 3.76 mg of TiO2 powder to the 
aqueous solutions and ultrasonicating (Eumax Ultrasonic Cleaner) for 5 min. A 
controlled amount of L-lysine (Aldrich, purity > 98%) was dissolved in the aqueous 
solutions and added to the particle suspensions. L-Lysine concentration was added with 
respect to the amount required (1 monolayer, ML) for the complete conjugation of the 
TiO2 surface metal atoms.  
The monolayer lysine concentration was estimated as follows: a maximal 
theoretical Ti–metal atom surface concentration of 12.43 atom nm2 was computed from 
the XRD composition and considering only the most thermodynamically stable surface 
planes of anatase (101) and rutile (110) and a spherical geometry of single diameter 
(dBET). All surface Ti atoms were assumed to be in this active hydroxylated 
configuration for stoichiometry calculations. In line with previous studies,27,28 five 
possible binding configurations of L-lysine to these Ti–OH binding sites were 
considered: (a) physisorption through (the more reactive) 3-amine, and carboxylate 
binding via (b) hydrogen bonding, (c) ester binding, (d) chelating and (e) bridging 
states. Cases (a) to (d) lead to a 1 : 1 ratio between –OH groups and lysine molecules, 
while (e) results in a 2 : 1 ratio. Based on the 1 : 1 configuration, excess, stoichiometric 
and sub-stoichiometric amounts of L-lysine were added to each solution. First, 10 mg, 
1.46 mg and 0.75 mg of L-lysine were dissolved into 1 ml of aqueous solution at the 
desired pH. This mixture was then added to the nanoparticle suspensions. The reaction 
proceeded at room temperature, with magnetic stirring at 600 rpm, and the effect of 
reaction time was investigated from 0 to 500 h. The functionalised nanoparticles were 
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collected from the reaction medium via centrifugation at 4000 rpm for 40 min. The 
particles were washed once in water and re-suspended in distilled water.  
A Zetasizer Nano S (Malvern) was used to measure change in zeta (z)-potential 
and hydrodynamic diameter (dH) between the as-prepared and lysine-conjugated 
nanoparticles. Transmission electron microscopy (TEM) (Hitachi 2100, operated at 125 
kV) was used to determine the formation of a polylysine matrix. ATR-FTIR (Bruker 
Alpha) was used to determine the resulting bonding type.  
Functional molecule loading and release  
The prepared TiO2 particle–lysine solutions were ultrasonicated in a bath sonicator 
(Eumax UD100SH-3LN, 100 W) for an additional 3 min to break-up potential soft 
agglomerates. Then, 10 ml of 1 mmol/L fluorescein isothiocyanate I (Sigma, purity > 
90%) diluted in a water/ethanol solution (e.g. 1 : 9 volume ratio) was added to the TiO2 
particle–lysine solutions to create dye-labelled nanostructures. To form ketoprofen–
lysine–TiO2 structures, 10 ml aliquots of lysine–TiO2 were first centrifuged at 4000 rpm 
for 50 minutes to remove supernatant and freeze dried for 2 h. Ketoprofen (5 mg) 
(Sigma, purity > 98%), and 4- (dimethylamino)pyridine (0.3 mg) (Sigma, purity > 99%) 
were dissolved in dry dichloromethane (30 ml) (Sigma, purity > 99.8%) and ethanol (20 
ml) (Sigma, > 99.8%) before adding them to dried lysine–TiO2 particles, followed by 
10 min of ultrasonication to form a suspension before the addition of Ncyclohexyl-N0 -
(2-morpholinoethyl)carbodiimide-metho-p-toluenesulphonate (4.6 mg) (Sigma, > 99%). 
Loading of both FITC and ketoprofen was performed at room temperature for 48 h with 
stirring at 300 rpm, after which the samples were centrifuged again at 4000 rpm for 50 
min to separate the product. The collected FITC and ketoprofen-terminated 
nanocomposites were suspended in water by ultrasonication for an additional 3 min.  
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These solutions were analysed by z-potential (Malvern Zetasizer Nano S) and 
UV-vis absorption measurements (Tecan M200Pro) to quantify the degree of loading 
and surface composition. To photocleave the ligand, the suspended product was 
exposed to UV light of 365 nm and 100 W (Spectroline Model SB700P/FA). The eluent 
was separated by centrifugation at 4000 rpm for 50 min. The effect of exposure time 
was investigated by dynamic light scattering and z-potential for each sample (Malvern 
Zetasizer Nano S). Primary amine fluorescamine assays were performed on the eluent 
by adding 100 mL of 1 mg/mL fluorescamine in DMSO to 300 mL of sample solution 
with fluorescence emission recorded at 470 nm (Tecan M200Pro).  
GC-MS was used to identify released lysine and ketoprofen. Samples were 
injected (0.2–1.0 ml injection volume) via an autosampler onto a Rtx-5MS fused-silica 
capillary column (Restek, Bellefonte, PA, USA; 30 m 0.25 mm id) coated with a 5% 
phenyl–95% dimethylpolysiloxane (0.25 mm film thickness), which was eluted with He 
(inlet pressure 14.5 psi) directly into the ion source of a Thermo Polaris Q GC/MS 
(injection port 220 °C; interface 250 °C; source 250°C). The column was temperature 
programmed from 80 °C (hold 1 min) to 300 C at 10 °C /min. The mass spectrometer 
was operated in the electron impact ionisation (EI) mode with ionisation energy of 70 
eV and scanned from m/z 50 to m/z 400.  
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Published with modifications:  
Zhang, T., P. Costigan, et al. (2016). "Disposable micro stir bars by photodegradable 
organic encapsulation of hematite–magnetite nanoparticles." RSC Advances 6(40): 
33843-33850. 
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Chapter Overview 
In the previous chapter, the flocculation of nanoparticles by the electrostatic attractions 
of surface-adsorbed amino acids was discussed as a negative attribute towards delivery 
of amine-active moieties such as the anti-inflammatory ketoprofen. In this chapter, the 
electrostatic interaction will be explored in more detail and will be exploited to produce 
stable self-assembled structures of iron oxide. A method using an applied external 
magnetic field to create anisotropic, needle-like structures will be presented. The 
governing parameters of magnetic field strength, magnetisation of the nanoparticle, 
nanoparticle concentration and solution pH will be discussed. A highly novel rotating 
behaviour under a dynamic magnetic field is presented and described. Finally, the 
usefulness of these structures towards improving local mixing on the microscale and 
overcoming the challenging diffusion-limited regime at such size scales, is 
demonstrated. A schematic of the overall materials synthesis and performance testing 
process is given in Figure 45.  
 
 
Figure 45. Chapter four overview.(a) Assembly of magnetic filaments, (b) dynamic response of filaments 
under rotating magnetic field, (c) micro-vortex-enhanced diffusion under a rotating magnetic field.  
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3.1 Lysine-assisted assembly of Isotropic structures 
The flame-made iron oxide nanoparticles synthesized at a [Fe]/O2 0.9 mmol/L 
were functionalised with lysine with an aim towards promoting the flocculation 
observed and avoided in the previous chapter. At a pH where both the iron oxide 
surface is negatively charged (pH> 7[338]) and the lysine is expressing amphoteric 
character (2.14 < pH < 12.48), neighbouring iron oxide nanoparticles should 
experience increased flocculation. This is in line with the results obtained for the 
previous chapter whereby TiO2 agglomeration was drastically increased at pH 9 
compared with pH 2.  
 First, a similar experiment was performed on iron oxide NPs at pH 4.6, 7.4 
and 8.8 in the absence of any externally applied magnetic fields. It was found that 
the resulting structures had an overall larger mean agglomerate size and a 
different morphology compared with the bare nanoparticles. The as-prepared 
flame-made iron oxides had an open fractal-like morphology, while the 
encapsulated agglomerates had a dense, close-packed structure (Figure 46). The 
apparent agglomerate size increased with reaction pH. In alkaline conditions, the 
formation of a thick encapsulating layer of lysine residues observed and 
agglomerates reached > 10μm in diameter. These results resembles that reported 
by other authors for polylysine-coated magnetic nanoparticles.[43]The growth of 
these structures was largely isotropic, with the mean aspect ratio recorded at 1.8. 
This implies that, in the absence of a magnetic field, the growth of these 
agglomerated structures was undirectional and governed primarily by random 
collisions in random directions.  
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Figure 46. (a) SEM and (b) TEM images of flame-made magnetite ([Fe]/O2 = 0.9 mmol/L) encapsulated 
in polylysine (PLL) at pH 8. 8 showing a nanorough surface morphology. 
 
 
3.2 Magnetic-field assisted assembly of anisotropic structures  
Next, an external magnetic field was applied perpendicular to the stirring plane 
and in opposition to gravity (see Materials and Methods) to promote anisotropic 
growth. Optical microscopy was used to determine the resulting structure. It was 
found that performing the amino acid functionalisation reaction under an applied 
magnetic field resulted in elongated structures of higher aspect ratios (Figure 47). 
These generally had a needle-like morphology with tapered ends that is similar to 
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that reported by Bharti et al. [169]. The main reaction parameters of interest were: 
the strength of the magnetic field, the reaction pH, and the magnetic properties of 
the nanoparticles. The distance of the permanent magnet source and thus the 
strength of the applied magnetic field was found to have a strong effect on the 
resulting stir bar morphology.. While the micro-bar’s width was not affected by 
the magnet distance, the average stir bar length increased drastically from 15 to 
100 μm with decreasing magnet distance from at 10 to 2.5 cm.  
 It is hypothesised that the primary driving force for the formation of these 
structures is the application of the magnetic field. The subsequent stability of this 
fibre-like structure is provided by two components: the amino acid residue/ 
encapsulation and the small remanence of magnetic field inside of the structure, 
both of which may have the effect of holding the chain of particles together.  
It was also noted that the fibre-like material had a tendency to further grow 
in length when under a magnetic field applied by a rare earth magnet. Care was 
taken to ensure that the rare earth magnet type, size and distance was kept equal. 
However, the growth of these fibres in situ should not be discounted.  
When compared against with the commercial magnetite nanoparticles, an 
important difference is observed. The commercial magnetite nanoparticles 
(Figure 47 g) resultedin the formation of significantly longer structures compared 
with the flame-made nanoparticles (Figure 47 e). However, from this result alone, 
it cannot be surmised whether this result is due to a difference in the particle size 
and shape, the magnetic character, or the difference in the amino acid 
adsorptions.  
 That author wishes to acknowledge that Figure 47 f, h are reproduced from 
the undergraduate thesis of Paul Costigan (supervised by the author).  
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Figure 47. Aspect ratio distributions of encapsulated PLL-FexOy as computed from optical microscopy 
(inset) and scanning electron micrographs (beside) for flame-made iron oxide and commercial magnetite 
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nanoparticles: (a) control with no magnetic alignment and (c,e) magnetically aligned flame-made 
nanoparticles ([Fe]/O2 = 0.3 mmol/L), and (g) commercial Fe3O4 nanoparticles. 
 
3.3 Modelling magnetic interactions 
To understand these observations in more detail, a model was constructed to 
describe the anisotropic assembly process. In addition to the field strength and 
magnetic properties of the material, an additional important parameter driving 
self-assembly is the initial agglomerate size of the iron oxide nanoparticles. 
Although the samples with a [Fe]/O2 of 0.3 mmol/L had a lower magnetic 
saturation, they also had a significantly larger agglomerate size (305 nm) than the 
samples with a [Fe]/O2 of 0.9 mmol/L (153 nm). Assuming that self-assembly 
proceeds predominantly by end-on-end addition in the direction of the applied 
magnetic field, the final aspect is proportional the number of collisions between 
agglomerates along the direction of the applied field that result in successful 
adhesion. The agglomerate size has a two-fold effect on the collision frequency. 
Equation 6 describes the collision frequency ZAB of agglomerate A, approximated 
as a sphere of radius rA, and the end of one rod-shaped structure with a half 
thickness/radius rB = rA. The ZAB is a function of the agglomerate radius and mean 
velocity of the colliding sphere v:                                            𝑍𝑍𝐴𝐴𝐴𝐴 = 𝑁𝑁𝐴𝐴𝑁𝑁𝐴𝐴(𝑟𝑟𝐴𝐴 + 𝑟𝑟𝐴𝐴)2𝜋𝜋𝑣𝑣    (Equation 6) 
Where ZAB = collision frequency; v = velocity; NA = number of colliding 
agglomerates with the bars; NB = number of colliding bars with the agglomerate; 
rA = rB = agglomerate radius. 
The velocity v can then be estimated by modelling the colliding 
agglomerate as a superparamagnetic sphere within a uniform magnetic field.[44] 
Only motion along the applied perpendicular magnetic field lines is considered 
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here. This is equivalent to neglecting the influence of the magnet nanomaterials 
on each other and assuming anisotropic growth occurs only along the direction of 
the dominant external field. It should be noted that in reality there will be 
attractive/repulsive forces between two neighbouring magnetic nanoparticles, 
although the magnitude of these forces should be small compared with that 
supplied by the external field. 
 Furthermore, Agglomerate motion by diffusion is also neglected as the 
Péclet number is ca. 22 for this system (see Appendices for details of the 
calculation). This indicates that ballistic motion driven along the magnetic field 
lines is the dominant over the randomly oriented diffusion path.[45]  
With these assumptions, the velocity term component of the collision 
frequency (Equation 6) may be expressed by considering the balance of the 
accelerating magnetic force and the decelerating drag force acting on an 
agglomerate (supplementary equations S1 - S15). Thus, the collision frequency is 
given by: 
                        𝑍𝑍𝐴𝐴𝐴𝐴 = 4𝑁𝑁𝐴𝐴𝑁𝑁𝐴𝐴𝑟𝑟2𝜋𝜋 �𝐶𝐶𝑒𝑒−18𝜂𝜂4𝑟𝑟2𝑡𝑡 + 3𝜒𝜒𝜇𝜇𝑚𝑚28𝜋𝜋2𝑥𝑥5𝜌𝜌�    (Equation 7) 
With η = liquid dynamic viscosity, t = time elapsed, χ = magnetic susceptibility 
of particle, μ = permittivity of liquid, x = distance from magnet, and ρ = density 
of the agglomerate. 
The exponential term can be neglected as the square dependency from the 
radius of agglomerates considered here (10-7 to 10-6 m) results in values 
approaching zero. As a result, the collision frequency is dependent on the second 
power of the agglomerate diameter and directly proportional to their magnetic 
susceptibility. Figure 48 shows the plot of the normalized collision frequency 
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( 𝑧𝑧𝐴𝐴𝐴𝐴
𝑁𝑁𝐴𝐴𝑁𝑁𝐴𝐴
) as a function of both agglomerate radius and magnetic susceptibility at 
normalized coordinates (t = 1 s, x = 1 cm). The results of this model suggest the 
critical impact of the agglomerate size when the magnetic susceptibility of the 
material is of similar magnitude, such as is the case for flame-made iron oxide 
nanoparticles. This effect may account for the higher aspect ratio of the sample 
with the higher initial agglomerate size (Figure 47 g) compared with the sample 
of lower agglomerate size (Figure 47e). 
The results also show the effect of magnetization of the starting 
nanoparticle material on the resulting microbar monodispersity. In all cases, the 
assembled microstructures possessed a greater geometric standard deviation 
compared with the initial nanomaterial, reflecting inhomogeneity inherent in the 
assembly procedure. However, the dispersity was lowest when the magnetisation 
was higher, such as for the commercial magnetite particles (σg = 1.58) (Figure 47 
g). The length of individual microbars relates directly to the size of its eddy when 
in rotation. Therefore, the geometric standard deviation of bars observed here will 
correlate to the dispersity in the size and speed of eddies during mixing. In 
turbulence, a wide distribution in eddy size and speed is typically observed. The 
wide distribution observed particularly for the flame-made sample (σg =3.96) 
(Figure 47 e) may render the material particularly suitable for turbulent mixing 
applications.   
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Figure 48. Modelling interaction agglomerate size and magnetic susceptibility on the collision frequency.  
 
3.4 Motion of anisotropic structures under an applied magnetic field 
The filament-like materials previously synthesised showed an interesting dynamic 
response towards any applied magnetic fields. Firstly, when a field is applied to a 
sample in wet suspension, the filaments arrange themselves to a highly uniform 
orientation that is parallel to the field direction (Figure 50 b). Additionally, there is net 
motion towards along the field gradient. When the field is rotated, these structures will 
attempt to follow the field, resulting in two types of motion: (a) rotation about the 
filament’s centre of mass, and (b) orbital motion around the centre of rotation of the 
magnetic field. This is in line with previous reports on similar structures.[15] In the first 
case, micro-scale vortices were generated resulting in turbulent mixing.  
Notably, no in-situ flocculation of the micro bars into larger structures was 
observed, highlighting their stability in suspensions. This may be attributable to the 
stabilising effect of the surface charge of the lysine-coated iron oxides in water. The 
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zeta potential was measured to be +13.4 mV for the lysine-functionalised filament 
structures, in line with previous observations. Flocculation of magnetic structures in 
aqueous solutions is usually driven by interaction of induced magnetic fields between 
neighbouring particles in addition to the usual van der Waals forces that are in play. 
This is counterbalanced by the electrostatic repulsion induced by the positively charged 
lysine coatings that exists in protonated form in water (NH3+/COO-/NH3+). In this case, 
the electrostatic repulsion is strong enough to overcome the attractive forces. 
This free, non-associating rotation is contrary to the ‘bundling’ behaviour 
reported by Bharti et al.[166] who observed that the flexible filaments initially aligned 
themselves within the stationary parallel magnetic field, but formed spherical bundles 
upon rotation that remained after the field was switched off and could not be reversed to 
their original, filament form. The improvement observed here is directly attributed to 
the difference choice of the functional molecule coating. Bharti et al. used lipids as the 
stabilising coating. Fatty acids adsorb to iron oxide surfaces via the –COOH group 
creating a lipid coating and leaving an exposed neutrally charged hydrocarbon chain on 
the outside of the nanoparticle.  This lipid coating promotes strong van der Waals 
interactions. Here, the presence of charged functional groups exposed on the outside of 
the structure appears to have a crucial effect.  
Video footage has been included with this dissertation that demonstrates the 
response of both a long filament-like structure (V1) and a random, agglomerated 
structure (V2) towards a rotating magnetic field. Figure 50 is a schematic of the three 
basic movement types observed.  
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Figure 49. Magnetically assembled filaments (b) under the influence of a magnetic field and (a) after 
field removal.  
 
Figure 50. Schematic representation of magnetic filaments undergoing (a) translational, (b) rotational 
and (c) orbital motion under applied magnetic fields. 
 
3.5 Using vortexing motion to improve microscale mixing  
Due to the vortexing behaviours observed by the rotating filaments, it was 
hypothesised that such a movement may aid in improving mixing/ dispersion in 
small voumes. Inducing adequate mixing at the nano-to-microscale is a signicant 
challenge. Such size scales are generally in the laminar flow regime and resulting 
mass transport is typically diffusion-limited. Additionally, nanostructures may 
experience a local viscosity that is higer than the bulk counterpart.[339] This was 
investigated by introducing a dilute suspension of the magnetic filments into a 
standard PDMS chip. It was found that the use of a magnet is crucial to direct the 
filaments during injection into the chip to avoid blockage of the microchannel 
110 
 
Chapter Three – Amino Acid-assisted Self-Assembly 
and to position the filaments at the mixing point. The microbars rotated at 
1500rpm with mininal horizontal displacement when positioned at the centre of 
the field of rotation. When applied within a dual stream system of water flowing 
beside trypan blue dye, the rotating magnetic filaments improved the mixing 
performance to a slight degree. An improved steady state diffusion profile across 
the width of the microchannel (Figure 51 b) compared with the low diffusion 
observed without (Figure 51 a).  
 
Figure 51. Flow of dye and water streams through a multichannel microfluidic chip (a) without and (b) 
with vortexing from magnetic filaments.  
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Chapter Summary 
In this chapter, lysine-assisted flocculation under a directing magnetic field was used to 
assemble anisotropic microstructures of iron oxide nanoparticles, proving the initial 
hypothesis that pH-controlled electrostatic interactions between amino acid-
functionalised nanoparticles can be exploited for self-assembly. The dynamics for this 
assembly were examined. It was found that the process may be modelled as dependant 
on the collision frequency. In this system, collision is influenced by the agglomerate 
size and the magnetic properties of the nanoparticles.  
 These filament-like structures exhibited several interesting responses towards an 
applied dynamic field, including translational, orbital and rotational motion. The 
rotation motion was used to create microscale vortexing that may induce improved 
mixing on the microscale, as hypothesised. However, it is not yet clear from the 
experiments presented in this chapter whether this vortex motion may in fact improve 
drug delivery rates.  
 The amino acid-coated iron oxide filaments presented in this chapter had a 
significant advantage over existing structures reported in literature to date. Most 
significantly, no irreversible ‘bundling’ (transition from filament to spheroid structure) 
upon rotating of the filaments was observed, neither was there any significant 
associative tendency between neighbouring filaments. This is an important 
advancement in the state of the art as this allows for the continuous rotation of the 
filament structures. This may be applied for the improvement of mixing rates on the 
microscale through microvortex action.  
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3.6 Materials and Methods 
Flame spray pyrolysis 
Iron oxide nanoparticles were synthesized using a flame spray pyrolysis (FSP) reactor 
(Appendices, Figure A4) as previously reported. The liquid organometallic precursor 
containing of Fe-ions (0.5–0.6 mol L−1) was prepared by mixing iron naphthenate 
(Strem chemicals, 80% in mineral spirits) in xylene (Fluka, purity > 98.5%). The 
solution was supplied through the FSP nozzle (at a rate of 3–5 mL min−1) and dispersed 
with oxygen at (2–9 L min−1) with a pressure drop of 5 bar. The resulting fine spray was 
ignited by an annular pre-mixed methane/oxygen pilot flame (CH4 = 1.2 L min−1, O2 = 2 
L min−1). Powder samples were collected with a vacuum pump (ICME Type M80B4) 
on water-cooled glass fibre filters (Sartorius glass microfiber FT-3-01124-150, 160 mm 
diameter) placed at 40 cm height above the burner. The resulting iron oxide nano 
powders were used without further purification. 
Functionalisation by lysine 
The magnetic micro-bars were synthesized by encapsulating the FSP-made iron oxide 
nanoparticles in lysine in an aqueous buffer solution. The buffer composition and pH, 
and iron oxide/coating material mass ratios were altered. In all cases, 2 mg of iron oxide 
powder was added to 10 mL of deionized water/pH 4.65 acetate buffer (Sigma-
Aldrich)/pH 7.4 phosphate buffered saline/pH 8.85 sodium borate buffer and mixed 
with appropriate mass of L-lysine (Sigma-Aldrich) according to the desired mass ratio 
formulation (0.2 mg, 2 mg and 20 mg). The resulting suspension was sonicated for 10 
minutes, then wrapped in foil and placed on a stirring plate at 1500 rpm for 24 h, 
directly beneath a strong rare earth magnet (N35, cylindrical, 2.54cm x 2.54cm, ca. 
5500 Gauss) supplying perpendicular vertical alignment field. The distance between the 
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top of the stirring plate and the bottom of the perpendicular magnet (HAS) was set 
according to experimental conditions. 
Characterisation 
X-ray diffraction analysis was performed with a Bruker D2 Phaser diffractometer 
operated at 30 kV, 10 mA at 2θ (Cu Kα) = 10–80°, step = 0.02° and scan speed 2.3° 
min−1. The crystal size (dXRD) was determined by Rietveld analysis with the structural 
parameters of identified iron oxide phases. The iron oxide powder specific surface area 
(SSA) was measured by BET analysis using a Micrometritics Tristar II after ca. 16 
hours degassing under vacuum at 120 °C. The BET equivalent diameter was calculated 
assuming primary particles and using the weighted average densities of iron oxide 
phases identified in the XRD analysis. The resulting micro-structures were imaged 
using optical microscope (Nikon Eclipse E200; TV lens 0.55× DS). Count distributions 
of mean bar length, width and aspect ratio were produced by measuring 200 bars for 
each sample using Image J software. Transmission electron microscopy was performed 
using Hitachi 7100 at 125 kV. 
Stirring performance 
Microchannel experiments were performed within a PDMS microfluidic chip, diameter 
500 μm. A dilute aqueous suspension of bars (ca. 1 mg/20 mL) was pumped into the 
microfluidic channel at 0.5 bar pressure (AF1 dual-microfluidic and vacuum pump, 
Elveflow). A magnet was placed at the centre of the chip to position the particles at the 
mixing point. Stirring was applied at 1500 rpm and photography performed using an 
iPhone 4s. Water, trypan blue dye (Sigma, 10 mg/10 mL in DI H2O) and dilute 
microbar suspension (2 mg/10 mL) streams were injected using syringe pumps (New 
Era Pumps) at 30 μL min−1. Rotation was once again performed at 1500 rpm 
(IKAMAG). 
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CHAPTER FOUR 
Synthesis of conductive iron oxide microfilaments using 
polypyrrole encapsulation 
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Chapter Overview 
This chapter will explore the synthesis of polypyrrole, an intrinsically conductive 
polymer of huge biomedical interest. In particular, it will focus on the electrical and 
photocatalytic properties of PPy with a view towards using this visible and near-
infrared-sensitive material as an alternative to the UV-sensitive TiO2 nanoparticles in 
previous chapters. The effect of including an amino acid (L-lysine or L-glutamic acid) 
on the resulting structural, chemical and optical properties is established over acidic, 
neutral and alkaline pH regimes. A Fluorescamine assay is used to assess the 
availability of free –NH2 in this doped material. Finally, a nanocomposite is synthesised 
comprising a Fe3O4 core and (amino acid-doped) PPy outer layer resulting in a 
magnetically responsive material. It was discovered that growing PPy onto nanoparticle 
surfaces was not trivial, in contrast with literature to date, and an optimisation of 
reaction conditions is given to produce raspberry-like composite structures. The 
photothermal effect of these materials is investigated. A schematic of the encapsulation 
process is provided in figure 52.  
 
 
Figure 52. Chapter 5 overview. (a) Synthesis of nanocomposites with Fe3O4 cores and glutamic acid-
doped polypyrrole coating (b) photothermal response of nanocomposites. 
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4.1 Amino acid doping of polypyrrole during chemical oxidative polymerisation 
The inclusion of negatively charged anions into the polypyrrole mass as counter ions is 
a well-established route towards doping of polypyrrole with functional molecules. 
However, despite the usefulness of amino acid-doped polypyrrole in applications 
including biosensing[340] and controlled drug delivery[283], there is little work done on in 
this. This is particularly true for chemical polymerisation, which remains a less 
commonly used route to produce amino acid-doped polypyrrole despite the advantages 
of this method in potentially producing nanoscale, composite structures as compared 
with the bulk scale films typically produced by electrochemical synthesis routes. At 
present, a systematic study focussing optimising chemical polymerisation of 
polypyrrole with amino acid dopants present is not available in the literature and thus 
forms the first research question of this chapter.  
It is expected that this synthesis process will be significantly influenced by the 
reaction pH, as for previous experiments using amino acids. It is known that pH has a 
strong effect on the synthesis of pure PPy, with greater extent of polymerisation 
favoured by lower pH.[341] This introduces an interesting conflict since higher pH is 
generally required to activate deprotonation of carboxyl groups (-COOH → -COO-) of 
amino acids. For example, the pKa for the carboxyls of L-lysine and L-glutamic acid are 
9.0 and 4.3 respectively.[224] Therefore, it follows logically that there exists an optimal 
reaction condition that favours electrostatic inclusion of the amino acid without overly 
inhibiting the polymerisation process. A study optimising this reaction for the resulting 
material properties such as optical absorbance, photothermal effect, extent of 
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polymerisation, and availability of the terminal –NH2 groups of the bound glutamate 
was conducted.  
Three reaction pH (2, 7, 10) were studied for L-lysine, L-glutamic acid and no 
dopant cases. Other parameters such as reaction time, temperature, concentrations and 
choice of oxidant were kept constant. It was discovered that the reaction pH and 
inclusion of dopant had a significant effect on the extent of polymerisation and 
appearance of products after a 24-hour reaction period over ice (Table 11). Most 
significantly, solid products were only evolved for undoped and L-glutamic acid doped 
PPy synthesised at neutral or alkaline conditions. These results suggest that the extent of 
polymerisation may be strongly influenced by the presence of the amino acid and is 
dependent on its charge state. In the case of basic type amino acid L-lysine, which is 
positively charged or neutral across the pH range studied here, its presence hindered the 
formation of the solid polymer product significantly. On the other hand, the acidic type 
glutamic acid has the two negatively charged –COO- did not seem to negatively impact 
the yield of solid PPy.  
Table 11. Initial observations for polypyrrole and doped polypyrrole synthesis after 24 hours at various 
reaction pH. 
 No Dopant L-glutamic Acid L-lysine 
pH 2 Black liquid Black liquid Black liquid 
pH 7 Black solid Black solid Black liquid 
pH 10 Black solid Black solid Black liquid 
 
The optical absorbance of these products revealed more information about the 
chemical structure of the resulting materials. The chain length and oxidation state of the 
polymer leads to overall differences in the available transition bands available within 
the material. Thus, the optical absorbance spectra of polypyrrole samples are indicative 
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of the chain length and oxidation state (Table 12) of the material. This property was 
equally effected by the reaction pH and amino acid dopant inclusion.  
Overall, neutral conditions (pH 7) promote dominance of lower energy 
absorption bands (2.67 – 2.76 eV) that are associated with the oxidised polymer form 
(Figure 53 a,b,c green lines). Additional bands at higher wavelength (1.81 eV; 1.35-1.56 
eV) are indicative of di-cationic polymer and longer oligomers (tetramer). The 
appearance of these bands especially at neutral reaction media suggest the overall 
greater degree of oxidative polymerisation achieved at pH 7. The formation of this 
product is generally desirable as it is the form with the useful high conductivity 
(relevant for electrical and electrochemical applications) and optical absorbance in the 
useful visible and infrared regions. At both highly alkaline (blue lines) and highly acidic 
conditions (red lines), the bands associated with neutral oligomers (dimer, trimer) 
dominate.  
Doping with ‘basic-type’ amino acid lysine inhibits the formation of polymer 
across all pH studied here (Figure 53 c). There is some emergence of the lower energy 
band at pH 10, where lysine exists in anionic form NH2/NH2/COO-. The polymeric 
bands are overall higher for glutamic acid doping compared with lysine, due to the 
acidic nature of glutamate and associated negative molecular charge state (Figure 53 b). 
However, doping with glutamic acid still results in a slight inhibition of the extent of 
polymerisation compared with pure polypyrrole.  
Table 12. Absorption bands of pyrrole derivatives and their assignation 
Wavelength (nm) Energy (eV) Assignation 
285-290 4.27 - 4.35 Dimer[342, 343] 
300-303 4.09-4.13 Dimer[344] 
316 3.92 Trimer[345] 
450 2.76 Dicationic Polymer[346] 
465-466 2.67 Cationic polymer (~10 
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rings)[256] 
685 1.81 Dicationic Tetramer[257] 
Dicationic Polymer[258] 
850-920 1.35-1.46 Dicationic Polymer[347] [345] 
 
  
 
Figure 53. UV-vis absorption spectra of polymerisation products of (a) pure polypyrrole, (b) glutamic 
acid doped polypyrrole, and (c) lysine doped polypyrrole at pH 2, 7 and 10. (d) Calculation of absorbance 
band ratio λ290nm/ λ460nm. 
 
The morphology of the products was assessed using TEM and BET in the case of the 
solid powders evolved at pH 2 and pH 7 for the pure and glutamate-doped PPy. It was 
found that for pure PPy acidic conditions resulted in the formation of large granules of 
ca. 1μm diameter (Figure 54 a), while neutral conditions favoured granules of ca. 350 
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nm diameter (Figure 54 b). This result is largely consistent with previous studies of 
(electrochemically) polymerised PPy films whose surfaces showed a similar relation of 
PPy granular size depending on the reaction pH.[348] In the case of electrochemical 
synthesis, this was correlated with the overall rate of polymerisation which was lower 
for the finer granules observed at pH. In the case of the glutamate-doped PPy, both 
doped samples consisted of finer granules (< 50nm), with a significant increase in 
surface area for pH 7 compared with pH 2. This is consistent with previous reports on 
the role of pH on synthesis of pure PPy, but contrary to the expectations based on the 
pH-dependence of the charge state of the L-glutamic acid. After all, L-glutamic acid 
exists as a negatively charged molecule (-COO-/ -COOH/-NH2) at pH 7 and a neutral 
one (-COOH/-COOH/-NH2) at pH 2. Therefore, following from the observations on the 
apparent charge-state dependant inhibition of L-lysine on the polymerisation of the 
doped PPy, it may be expected that the granules of glutamate-PPy produced at pH 7 
should have an overall larger size/ lower surface area consistent with a faster growth 
rate.  
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Figure 54. Scanning Electron Microscopy of (a) polypyrrole synthesised at pH 2, (b) polypyrrole 
synthesised at pH 7, (c) glutamic acid doped polypyrrole synthesised at pH 2, and (d) glutamic acid doped 
polypyrrole synthesised at pH 7. 
 
Although the optical properties give a good indication of the polymer chain 
length and oxidation, they indicate nothing about the presence (or not, as the case may 
be) of the amino acid as the bound counter ion within the PPy mass. After all, there 
remains the possibility that the amino acid has not been included with the PPy 
preferring to take up the anions from the oxidant (SO42-). Unfortunately, successful 
amino acid doping via a chemical polymerisation is currently not known in literature, 
although the electrochemical counterpart has been well-documented[349]. Therefore, 
FTIR spectra were collected for the washed and freeze dried glutamate-PPy samples to 
confirm the amino acid presence.  
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At both pH 2 and pH 7, the pure PPy spectra was a good match for the known 
spectra of pure PPy (Figure 56 a,b black lines) and consistent with previous data. The 
Emergence of –CH2 bands ca. 3000 cm-1 that occurs for the glutamate-PPy samples 
(Figure 55 a,b green and red lines) may be indicative of binding of glutamic acid. -
COO- bands at ca. 1400 appear only for glutamate-PPy samples. However, this peak is 
small and may be overlapped by nearby PPy peaks. Overall, these spectra suggest that 
the glutamate is present within the dried, solid PPy mass, indicating successful inclusion 
of the amino acid as a counterion dopant. The peak identifications used for indexing of 
these spectra has been given in Table 13.  
Finally, to confirm the reactivity and content of the –NH2 groups within the 
doped samples, a fluorescamine assay was used, following the same procedures as for 
lys-TiO2 from previous chapters. Both samples showed a similar concentration of –NH2 
(Figure 56). Although a slightly higher value was recorded at pH 7 compared with pH 2, 
due to the significant offset on the baseline on the long wavelength side between the 
two spectra, this may not be meaningful. These results simply indicate that for both 
samples prepared, there is a content of reactive -NH2.  
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Figure 55. FTIR of PPy (black lines) and glutamate-doped PPy (red and green lines) polymerised at (a) 
pH 2 and (b) pH 7.  
 
 
Table 13. Assignation of FTIR peaks 
Wavenumber (cm-1) Assignation Reference 
2970 -CH2 stretch [350] 
1695 NH3+ stretch or α-COO- stretch (Glut) [351] 
1560 Ring vibration (PPy) [352] 
1450 Ring vibration (PPy) [352] 
1397 α-COO- or γ-COO- stretch (Glut) [351] 
1197 -CH2 rocking (Glut) [351] 
1090 C-N stretching (PPy) [353] 
1029 N-H in plane deformation (PPy) [353] 
920 Out of plane =CH vibration (PPy) [354] 
780 Out of plane =CH vibration (PPy) [354] 
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Figure 56. Fluorescamine assay of glutamate-doped PPy synthesised at pH 2 (red line) and pH 7 (green 
line) 
4.2 Nanoparticles as seeds during polypyrrole polymerisation 
Having established the successful doping of the PPy with glutamate ions, iron oxide 
nanoparticles were introduced as seeds during chemical polymerisation to create a 
composite material. A black particulate product was obtained and purified by a 
combination of magnetic separation and washing.  
Transmission electron microscopy was performed on the resulting product, 
confirming the formation of a structure comprising an iron oxide nanoparticle core (dark 
phase) surrounded by the PPy (lighter phase) (Figure 58). This was further supported by 
the FTIR spectra that show the typical peaks of PPy (blue line) after polymerization 
reaction, compared with that of pure iron oxide (red line), with evidence of additional 
peaks that match well with those of PPy as reported in literature (Figure 59) These may 
be attributed to C=C/C-C stretching[355] (1560 cm-1), C-H in-plane deformation (1190 
cm-1), N-H in-plane deformation (1040 cm-1) and C-H out-of-plane deformation (910 
cm-1).[356] 
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The morphology of the resulting polypyrrole-Fe3O4 composite structures was 
found to be dependent on two factors: the choice of oxidant and the mass ratio between 
the pyrrole monomer and the Fe3O4 NPs. For the APS oxidant sample set (Figure 57), 
two different structures were observed. At high pyrrole:Fe3O4 ratios between 10:1 and 
2:1 (Figure 57 a,b,c) a product comprising of an iron oxide core surrounded by small 
(<5nm) PPy nanoparticles was produced. This “raspberry-like” formation with a larger 
central Fe3O4 core surrounded by smaller, well-defined PPy granules has hitherto not 
been reported for composites of iron oxide and PPy. The granule size of the PPy was ca. 
10-20 nm. This is significantly smaller than that typically reported for simple chemical 
synthesis of PPy using APS without dopants or micro-emulsion strategies, which is 
usually in the range of 200 – 700 nm.[357] At lower pyrrole:Fe3O4 ratios, the product 
consisted of an aggregated structure comprising polypyrrole partially surrounding but 
largely separate from the Fe3O4 NPs (Figure 57 d,e). This is more consistent with 
existing reports of PPy-Fe3O4 composites in the absence of copolymers or surfactants. 
These structures observed were contrary to expectation. It was initially 
hypothesised that the nanoparticle would act as seeds for the polymerisation, and 
therefore that nucleation would begin preferentially at the nanoparticle surfaces. 
However, the results presented in Figure 57 directly oppose this hypothesis. The 
“raspberry-like” structure was created at higher concentrations of pyrrole and lower 
concentrations of the monomer resulted in aggregation away from the nanoparticle 
surface. Based on this observation, an alternative explanation is proposed. It is possible 
that the dominant mechanism is homogenous nucleation randomly throughout the 
solution. At higher pyrrole concentrations, there was a greater likelihood of some 
portion of the polymer granules growing upon the nanoparticle surface. This is 
supported by the observation that, in all cases except for 1:10 pyrrole: Fe3O4 ratio, there 
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was excess polymer formed that did not include Fe3O4 nanoparticles and were not able 
to be collected by magnetic separation.  
 
Figure 57. Transmission electron micrographs Fe3O4 NPs (dark phase) coated in PPy (light phase) via 
APS oxidant route at (a) 10:1, (b) 5:1, (c) 2:1, (d) 1:1 and (e) 1:10 pyrrole:Fe3O4 mass ratio. 
  
An FTIR analysis of the raspberry-like structures resulting from APS oxidised 
synthesis (at 10:1 Pyrrole: Fe3O4 mass ratio) clearly identified the presence of PPy with 
its characteristic peaks (Figure 58, red line) that are absent in the pure Fe3O4 material 
(Figure 58, blue line).  
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Figure 58. FTIR for Fe3O4 NPs (red line) and PPy-Fe3O4 composites created using APS synthesis route at 
10:1 pyrrole: Fe3O4 mass ratio.  
 
In an attempt to improve the polypyrrole coating, a sample set was produced 
using FeCl3.6H2O as the oxidant. This is based on the current reports that the common 
ion effect will result in Fe3+ ions adsorbing onto the Fe3O4 NPs and thus serving as a 
site for polymerisation to begin at the seed particle surface[358]. The resulting products 
are presented below (Figure 59). The structures obtained were interesting and partially 
consistent with literature reports. It was discovered that with the FeCl3.6H2O oxidant, an 
aggregated structure was only formed at high pyrrole ratios (Figure 59 a,b), while at 
ratios of 1:1 and below (Figure 59 c,d,e), a coating was observed on the nanoparticle 
surface. The morphology of this coating was unexpected, however. While Chen et al. 
observed a smooth, amorphous layer of PPy, here an urchin-like structure was observed. 
This is particularly prominent at 1:1 ratio (Figure 59 c), and is novel as far as the author 
is aware.  
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Figure 59. Transmission electron micrographs Fe3O4 NPs (dark phase) coated in PPy (light phase) via 
FeCl3.6H2O oxidant route at (a) 10:1, (b) 2:1, (c) 1:1, (d) 1:2 and (e) 1:10 pyrrole:Fe3O4 mass ratio. 
 
The experiment was then repeated using glutamic acid dopant synthesised at 
neutral (pH 7) conditions. The inclusion of a dopant did not seem to change the overall 
morphology of the composites (Figure 60 a) which appeared broadly similar to those 
without dopant (Figure 57 a). Upon close inspection, grains appeared slightly smaller in 
the doped sample (ca. 5nm for doped sample compared to ca. 20nm for undoped), 
which is in line with previous findings on doped PPy granular size (Figure 54).  A slight 
change to the optical properties of the resulting doped composite was also recorded 
(Figure 60 b, green line), compared with the undoped composite (Figure 60 b, black 
line). The doped material shows a proportionately stronger absorbance in the visible 
compared to the infrared against the undoped standard. This may be of minor 
importance for photothermal applications.  
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Figure 60. (a) TEM of glutamate-doped PPy granules in raspberry-like structure around iron oxide cores. 
(b) Optical absorbance spectra of PPy-Fe3O4 (black line) and Glut-PPy-Fe3O4 (green line). 
 
The optical properties of the Fe3O4 -containing composites were assessed 
(Figure 61 b) and were consistent with those previously found for PPy and glutamate-
PPy, showing a strong absorbance peak at 470 nm and a broad peak in the infrared 
beginning at 700 nm. An attempt was made to characterise the photothermal properties 
of this material using light at 470nm provided by an LED matching the sharp visible 
range absorption peak. Although most studies focus on the use of NIR lasers, in this 
particular case, the peak in the visible range appeared stronger than the broad infrared 
band. A mild photothermal effect was recorded for the polypyrrole-coated Fe3O4 NPs 
compared with the controls (Figure 62). This effect was stronger for the PPy-Fe3O4 
composites produced from a higher PPy to Fe3O4 ratio resulting in the aggregated 
products (Figure 58 c). This may be attributed to the overall greater photothermal PPy 
content in these samples compared to the samples produced at a lower PPy:Fe3O4 ratio. 
An additional effect may be the distribution and effective surface area of these 
a b 
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composites. For the “raspberry-like” structures obtained at 10:1 PPy:Fe3O4, the even 
distribution of the granules and their increased effective surface area compared with the 
aggregated case at 1:1 may enhance the heat transfer out of the granules and into the 
surrounding liquid.  
 
Figure 61. Photothermal effect of PPy-Fe3O4 nanocomposites in raspberry-like (red squares) and 
aggregated (blue triangle) structures compared against control without light (black circle) and control 
with visible light (470nm) and no nanoparticles (white circle). 
 
Overall, this photothermal effect is less strong than that typically reported in literature 
for PPy. For example, Chen et al. was able to reach 50°C within 10 minutes at even 
lower concentrations of PPy.[359] The threshold for cellular death (of cancerous and 
noncancerous cells alike) is generally reported to be in the order of 70 - 80°C. The weak 
photothermal response reported here is therefore not directly useful for photothermal 
therapies. This difference in performance may result from the light source used here. It 
should be noted that 808nm lasers are overwhelmingly preferred in literature for the 
activation of PPy, and is feasibly that the low-energy LED light used here is the primary 
cause of the difference observed. However, there are applications that can make use of a 
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small temperature increase as seen here. For example, a temperature increase of 5°C is 
enough to trigger a payload release out of a hydrogel.[360]  
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Chapter Summary 
The initial hypothesis that the pH will have a significant effect on the doping of PPy 
with amino acids was proven to be correct. It was found that between pH 2 – 10, 
including L-lysine in the polymerisation reaction strongly inhibits the formation of a 
solid polypyrrole product. For L-glutamic acid, a solid product was formed at pH 2 and 
7. The product consisted of overall smaller granules than the undoped equivalent that is 
indicative of a decreased polymerisation rate. It was found that the polymerisation rate 
for glutamate-PPy may be enhanced at pH 2 compared to pH 7. However, the content of 
reactive –NH2 groups may be a small degree higher at pH 7 due to dominant effect of 
the molecule’s more negative charge state at this pH on its incorporation into the PPy 
mass. To date, a systematic study of the effect of the reaction pH on these resulting 
properties has not been presented in literature, and the results here represent a novel 
contribution that that may be broadly applicable for applications that use amino acid 
doped polypyrrole.  
 The chemical synthesis of solid granules of (glutamic acid-doped) PPy was 
adapted to create nanocomposites with iron oxide using a one-step nanoparticle-seeded 
polymerisation. Two main morphologies (raspberry-like and aggregated) were 
documented, and the pyrrole-to-Fe3O4 NP mass ratio was found to be crucially 
important to the resulting morphology. The raspberry-like formation was new and has 
not been previously observed by other scholars for such a simple, surfactant-free 
synthesis.  This composite material displayed a photothermal effect when exposed to an 
LED source matching its main absorbance peak in the optical wavelength range (ca. 
470nm). However, it should be acknowledged that this effect was weak compared with 
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the state-of-the-art as reported in literature. The weakness of this response is attributed 
to the LED light source being of lower power. A tuneable NIR laser is standard in 
literature.  
4.3 Materials and Methods 
Materials 
Pyrrole (98% purity), Ammonium Persulfate (98% purity), Iron (III) Chloride (97% 
purity), Hydrochloric Acid (37% solution), Sodium Hydroxide (97% purity), L-
glutamic acid (99% purity) and L-lysine (98% purity) were purchased from Sigma-
Aldrich and used without further purification.  
 
Polymerisation of PPy with amino acid dopants 
A 10 mL sample of DI water was measured and placed over ice. To this, 10 mg of 
amino acid (L-glutamic acid or L-lysine) was added and stirred until dissolved. 100 µg 
of pyrrole was then added and stirred vigorously using a magnetic stirring bar and plate 
(1500 rpm) until a uniform emulsion is formed. Then the solution was titrated to the 
correct pH by adding either 0.1 mol/L NaOH or 0.1 mol/L HCl while monitored by a 
pH probe (Oakton pH 700). In a separate vial, 10 mg of APS was measured out and then 
added to the above. The reaction was kept in dark conditions over ice with 1500 rpm 
stirring for 24 hours unless otherwise stated. The sample was collected using gravity 
filtration and washed in methanol (1x), ethanol (3x) and water (3x) before being freeze 
dried.   
Polymerisation of PPy with nanoparticle seeds 
A 1 mg sample of Fe3O4 NPs was added to 10 mL of DI water and ultrasonicated for 3-
5 minutes until a uniform suspension was formed. Then a measure of either APS or 
FeCl36H2O was added and mixed over ice until the oxidant dissolved. To this, a 
measure of pyrrole (10 mg, 5 mg, 2 mg, 1 mg, 100 µg) was added. The mixture was 
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kept in dark conditions over ice with 1500 rpm stirring for 24 hours. The mass ratio of 
oxidant to pyrrole was 1:1. The sample was collected by placing a magnet on one side 
of the vessel and removing the excess reagents by pipet. The sample was washed in 
methanol (1x), ethanol (3x) and water (3x) by adding the wash liquid and shaking 
vigorously before repeating the magnetic separation. The samples were then freeze 
dried.   
Characterisation 
The resulting products were imaged using scanning electron microscopy (Zeiss Ultra) 
and transmission electron microscopy (Hitachi 7100, 125kV). FTIR was performed 
using Bruker Alpha. Optical absorbance spectra were obtained from a Tecan M200 Pro.  
 
Fluorescamine Assay 
A 1 mL solution containing 100 µg /mL of the product was prepared by weighing the 
freeze-dried product and ultrasonicating for 3 minutes in water. 300µL of this was taken 
and added to 100µL of 1mg/mL Fluorescamine solution in DMSO. The mixture was 
shaken vigorously then left for 10 minutes to react before being transferred to a well 
plate (96 well Costar, flat bottom) for UV-vis analysis (Tecan M200 Pro).  
 
Photothermal Experiments  
A 1 mL solution containing 100 µg /mL of the product was prepared by weighing the 
freeze-dried product and ultrasonicating for 3 minutes in water.  This was placed in a 
1.5mL Eppendorf tube. An LED (either 479nm or 800 nm, operated at 10mA) was 
placed at the side of the sample at a distance of 5mm.  Temperature readings were taken 
by a probe that was inserted in the Eppendorf at ca. 5mm below the surface of the 
solution. Prior to the experiment, the temperature was allowed to stabilise for 30-
60minutes (as required until a constant value was reached).  
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Chapter 5 Polypyrrole-coated iron oxide filaments  
 
 
CHAPTER FIVE 
Polypyrrole-coated iron oxide filaments for rotation-
assisted release
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Chapter Overview 
In this chapter, the findings of previous chapters are combined to create a magnetically, 
electrochemically and optically responsive material that can be used to not only release 
functional molecules upon stimulation, but also can be used to enhance diffusion of 
those materials away from the carrier much more quickly than traditional diffusion-
limited systems. A strategy to synthesise a magnetic filament comprising Fe3O4 cores 
surrounded by PPy is described and the directionally-dependant electrical properties of 
the resulting materials are characterised. L-glutamate is doped into the PPy, and 
electrochemical stimulation of the filament is used to activate release of the functional 
amino acid. Finally, FITC dye is used to visualise the rotation-enhanced diffusion rate 
of molecules out of the nanoplatform. The overall process of encapsulation, alignment, 
conductivity testing and release experimentation is illustrated in figure 63.  
 
 
 
 
Figure 62. Chapter 6 overview. (a) Synthesis of glutamic acid-doped polyrrole-coated Fe3O4 filaments, 
(b) directional conducitivity, (b) electrochemical dedoping of glutamate.  
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5.1 Synthesis of PPy-Fe3O4 filament structures 
The typical PPy synthesis was adapted for magnetically aligned filament synthesis by 
adapting the strategy discovered in Chapter 3 combined with the nanocomposite 
synthesis explored in Chapter 4 using the APS oxidisation pathway. It was found that 
direct synthesis of the microfilaments in one-step (seeded polymerisation of polypyrrole 
under a direct applied magnetic field) was less effective in the creation of filaments 
when using a polypyrrole coating compared to the amino acid coating in chapter 3. 
Significant polymerisation was initiated away from the nanoparticle surface even a the 
conditions previously established to create core-shell, raspberry-like structures when 
done without the aligning magnetic field.  
Instead, a two-step procedure is preferred. Here, the premade core-shell nanomaterials 
are arranged by applying a parallel, horizontal magnetic field, as per Bharti et. al.[166]. 
This resulted in the formation of long filament-like structures (Figure 64 b) compared 
with the typically spheroid products usually produced by PPy encapsulation of Fe3O4 
(Figure 64 a) and is similar time with previous results on amino acid coated iron oxide 
nanomaterials as presented in chapter 3. The filament-like structures had an average 
length of ca. 138μm. The filaments were highly disperse, showing a high standard 
deviation in filament length (σg = 1.83) (Figure 65) that is consistent with grow 
mechanism that is dominated by random collision followed by successful adhesion.  
The TEM (Figure 64 c,d) showed the microstructure of the filament with 
evidence of the encapsulation polypyrrole coating (light phase). It was found that the 
PPy was not in a raspberry-like form around the Fe3O4 cores as for the isotropic 
encapsulation at the same pyrrole:Fe3O4 ratios (Chapter 5, Figure 58a), but rather in an 
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aggregated, amorphous form. It is not clear why this difference was observed. One 
possibility is that the raspberry-like form is not robust enough to withstand the magnetic 
field induced collisions.  
 
Figure 63.Optical micrograph showing (a) isotropic product typical of synthesis in the absence of 
magnetic field and (b) filament-like structures aligned in applied magnetic field direction. (b) Length 
distribution and (c, d) transmission electron micrographs of the same.  
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Figure 64. Length distribution of PPy-Fe3O4 microfilaments. 
 
5.2 Electrical properties of anisotropic structures 
The filaments displayed highly anisotropic electrical conductivity arising from the PPy 
coating. When aligned parallel to the interdigitated electrode array by the action of an 
externally applied magnetic field (Figure 66 a), the relatively high discontinuity in the 
filament arrangement leads to a high resistance recorded of 5.3 MΩ. However, upon 
rotating the field to act in the perpendicular direction, resulting in higher continuity 
between the electrodes, the resistance decreases by a factor of 300 down to 16.5kΩ 
(Figure 66c). It was found that the conductivity scales linearly with the concentration of 
filaments (Figure 67), as may be expected.  
This result is novel as far as the author is aware. This direction-dependant 
conductivity may be useful for magnetically-actuated switching of microcircuitry. 
However, in this dissertation, it is relevant to the electrochemically activated dedoping 
/drug release mechanism.  
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Figure 65.  Micrographs showing alignment and corresponding resistance of PPy-Fe3O4 microfilaments 
in (a) parallel, (b) 45° oblique and (c) perpendicular to electrode array. 
 
 
Figure 66. Recorded resistance of PPy-Fe3O4 microfilaments arranged perpendicular to the electrode 
array at various concentrations.  
 
5.3 Electrochemical dedoping of glutamate  
Given the promising electrical properties that were discovered, an electrochemical drug 
release experiment was devised using a glutamate-PPy coated Fe3O4 filament that was 
produced by including L-glutamic acid in the typical polymerization solution, as per 
Chapter 4. The filament product was then aligned over electrodes in a PBS solution (in 
the more conductive, perpendicular arrangement (Figure 67 a) and a -5V potential 
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applied in order to forcibly reduce the PPy and thus release the glutamate dopant 
electrochemically (Figure 68 a,b).  
The glutamate was assayed by taking aliquots of the particle-free solution and 
then using the same fluorescamine assay as in previous chapters. A significant increase 
in the free glutamate content was confirmed after applying the potential compared with 
the control over the same conditions (Figure 68 c), illustrating the effect of 
electrochemical dedoping action. It should be noted that the control did not show a zero 
glutamate baseline. This can be attributed to the passive leaching of glutamate out of the 
PPy. A similar passive release effect has been consistently reported for other dopants 
into PBS solution. For example, dexamethasone[361] and ciprofloxacin[362] will both 
show a passive diffusion profile. In fact, this passive, slow sustained release is itself 
useful method of drug delivery. However, the ability to enhance this and create an 
increased burst of the loaded molecule as required, such as is shown here, creates 
additional possibilities and is a significant result.  
 
Figure 67. (a, b) Schematic illustrating electrochemical dedoping of bound glutamate anions by applying 
a negative potential. (c) Fluorescamine assay of particle-free solution for perpendicular aligned glut-PPy-
Fe3O4 filaments in PBS after 2 min with no applied potential (black line) and -5V (red line). 
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5.4 Magnetic-rotation assisted delivery 
In Chapter 3, the ability of rotating filaments to create local mixing vortices was shown. 
In the previous section, a sustained passive release of the dopant from the PPy was 
observed. Following these two observations, an experiment was devised combining 
these observations in order to use the microscale vortexing of rotating filaments to 
improve the diffusion rate of materials out of the polypyrrole coating, thus giving 
another method of creating controlled, burst release.  
Here, to visualise the possibility of enhanced release, a fluorescent dye (FITC) 
was bound to the PPy-Fe3O4 filaments by including the dye during standard chemical 
polymerisation. The elution of this dye out of the filaments in PBS was observed with 
and without a rotating magnetic field (Figure 69 a,b). It was hypothesised that, since the 
passive elution is usually diffusion-limited, introducing the rotating action will enhance 
the diffusion rate by introducing eddy mixing local to the microfilament.  Figure 69c 
shows the time lapse of this dye as it diffuses away from the microfilaments and 
confirmed this hypothesis. A significantly faster rate was observed for the rotating 
filaments compared to the stationary control case. The release rate was correlated to the 
rotation speed, increasing with increasing rotation rate as expected.  
This is a significant result as it gives an alternative pathway for loading and 
release that has not been previously proposed in literature to date. It is possible to 
imagine a system that uses a stationary magnetic field source to locate and move the 
loaded microfilaments to location and then creates controlled, fast release by rotating 
the field. Such a system would be a potentially impactful lab tool. However, the author 
wishes to acknowledge that further studies are required before this may be implemented 
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to in vivo experimentation. Firstly, the currently large size of the microfilaments (in the 
100 µm scale) is not compatible with biological systems due to mobility issues. 
Secondly, the rapid, propeller-like motion may cause significant cellular damage, 
although studies are lacking in this area. If properly controlled, this may create a 
synergistic effect that is suitable for cancer treatment as per other cytotoxic methods 
such as photothermal treatment[363]. However, this remains a distant application at this 
stage and is far beyond the reach of this dissertation.  
           
 
Figure 68.Timelapse of eltuion of FITC from PPy-Fe3O4 filaments at variable rotation 
rates. 
  
c 
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Chapter Summary 
In this chapter, a synthesis for PPy-encapsulated Fe3O4 filaments was presented based 
on successfully adapting protocols established in previous chapters. It was found that 
the morphology of the anisotropic material was different from the isotropic material at 
the same experimental conditions and may point to the significance of the seed surface 
area-to-pyrrole monomer ratio.  
The resulting material displayed interesting anisotropic electrical properties 
deriving from the PPy coating. By manipulating the externally applied magnetic field, it 
is possible to control the direction of the magnetic filament relative to the electrodes and 
obtain a 300 fold change in conductivity by rotating through 90o. 
 By applying a negative potential to a filament structure with a doped glutamate-
PPy coating, it was possible to induce a burst release of the glutamate ion into solution 
via electrochemical reduction. This presents another, electrochemical route towards 
controlled delivery.  
Finally, the filament-like structures showed similar responses to a dynamic 
magnet field as before. The rotation behaviour was used here to improve the elution rate 
of a model molecule (FITC dye) whose release from a PPy matrix is ordinarily 
diffusion-limited, demonstrating the concept of rotation-assisted delivery from such a 
system.  
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5.5 Materials and Methods 
 
Synthesis of PPy-Fe3O4 filaments 
A 1mL sample of Fe3O4 NPs was dispersed in 10 mL of DI water by ultrasonication for 
3 minutes until an even suspension was formed. 100 µg of pyrrole was added this and 
mixed until an emulsion formed. Where appropriate, 100 µg of L-glutamic acid was 
added to the above and stirred until fully dissolved. Then 100 µg of APS was dissolved 
in 0.1 mL of DI water. The solution containing Fe3O4 NPs/ Pyrrole was placed into a 
wide, shallow vessel above a magnetic stirring plate operating at 1500 rpm. A rare earth 
magnet was placed above the vessel at a distance of ca. 2.5 cm above the stirring plate 
(see Appendices Section 3. Magnetic alignment setup). The solution containing APS 
was then added dropwise to the solution contain Fe3O4 NPs/ Pyrrole. The reaction was 
kept in dark conditions and allowed to react for 24 hours. The resulting materials were 
removed using a pipette and placed into a conical tube (Falcon, 50mL). A magnet was 
placed on the side of the sample and the excess solution removed by pipette. The 
material was washed in methanol (1x), ethanol (3x) and water (3x) by gently shaking 
with the wash liquid, then repeating the magnetic separation.  
 
Material Characterisation 
The filaments were characterised using an optical microscope at 10x magnification and 
transmission electron microscope (Hitachi 7100, 125kV).  
 
Electrical conductivity 
A 50µL drop containing 100 µg/ mL of the filaments was placed on top of an 
interdigitated electrode array (Dropsens). A rare earth magnet was then used to align the 
filaments relative to the electrodes with aid of an optical microscope. The sample was 
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allowed to dry overnight before resistance measurements were made using a multimeter 
(Keithley)  
 
Electrochemical Dedoping 
A sample comprising a dried arrangement of glutamic acid-doped polypyrrole Fe3O4 
filaments on a Dropsens electrode array was placed at the bottom of a vessel containg 
ca. 1mL PBS. A -5V potential was passed through the electrode with a Pt counter 
electrode for 2 min. Then, a 100µL sample of the PBS solution was taken and added to 
30µL of 1mg/1mL fluorescamine in DMSO and reacted for 10 min before UV-vis 
analysis (Tecan M200Pro).  
 
Binding and dispersion of FITC dye 
A dye was included in the synthesis of PPy-Fe3O4 bars by first preparing 1mg FITC in 
10mL H2O. 1 mg of Fe3O4 was then added to this and sonicated for 3 minutes. 100µg of 
pyrrole was added and shaken until an emulsion formed. This mixture was placed in the 
same setup as before (Appendices Section 1). 100µg of APS was dissolved in 100µL of 
DI water and added to the above dropwise. The reaction was allowed to proceed for 24 
hours in dark conditions with a constant 1500 rpm.  The sample was collected and 
washed as previously. A 50 µL sample of solution containing 100µg/mL of the product 
was injected into a 45mm petri dish containing 10mL of PBS buffer solution using a 
Gilson P200. The photography was recorded on a Sony Xperia Z5.  A blue LED was 
used to improve the visibility of the fluorescent dye.  
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Chapter Six – Conclusions and Outlook 
In this dissertation, a broad range of results pertaining to several important topics in 
nanomaterials for drug release were shown.  
Firstly, a photocatalytic system based on amino acid-functionalised TiO2 was 
presented. This system was able to bind and release –NH2 reactive molecules as 
modelled by FITC dye and anti-inflammatory drug ketoprofen. The overarching 
importance of reaction pH in directing the interaction of amino acids with metal oxide 
surfaces determined. An acidic condition favours binding of the amino acid by the –
COOH group(s) to the metal oxide surfaces, a configuration that is favourable for 
subsequent binding of useful moieties to the terminal –NH2. The mechanism of the 
photocatalytic release of adsorbed molecules was clarified by experimentation. Upon 
illumination with UV-A, there is simultaneous release and redox cyclization of the 
amino acid recorded. Where the amino acid is terminated by the model drug ketoprofen, 
it is possible to release the drug via this photocatalytic pathway. In all experiments 
conducted, there exists an optimal illumination time after which the degradation of the 
surrounding organic materials overtakes their release into solution. This time period was 
found to be between 5-10s. This is a novel observation so far not reported in literature.  
The reaction pH of amino acid functionalization will also cause a significant effect 
on the flocculation dynamics of the nanoparticles in question. Aggregation is promoted 
by higher pH and higher concentrations of the amino acids. The mechanism is most 
likely electrostatic interaction between nearby –NH3+ and –COO- groups. This 
flocculation may be exploited to assembly anisotropic filaments of Fe3O4 nanoparticles 
under a directing magnetic field. These magnetic filaments responded to an applied 
rotating magnetic field to create microscale vortices that aid local mixing and may be 
helpful in overcoming typically diffusion-limited delivery applications.  
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The doping of polypyrrole with amino acids was also discovered to be pH-
governed with favourable oxidation of pyrrole monomer and doping of the resulting 
polymer only occurring at pH where the amino acid existing in an anionic form. 
Conversely, protonated, cationic –NH3+ groups present will inhibit the oxidative 
polymerisation of polypyrrole. When polypyrrole is used as a coating for the magnetic 
filament structure, a directionally dependant conductivity is observed that can be 
controlled by changing the direction of the external magnetic field. The glutamic acid-
doped polypyrrole can be electrochemically dedoped, presenting an alternate controlled 
delivery route. With an appropriate payload adsorbed in the PPy matrix (modelled with 
FITC dye), the rapid vortexing motion of the magnetic filaments can be used for a 
rotation-enhanced delivery mode that is novel in literature to date.  
Although several important results were obtained, there remain several 
unanswered questions and avenues for future scholarship. Going forward, the following 
directions may y 
1. Improve the structure of the magnetic filaments 
The magnetic filament structures created in Chapter 3 and Chapter 5 should be 
improved. In particular, their large size distribution is currently far from ideal. Due to 
the proposed growth mechanism by collision, a random event following a natural 
distribution, it is unlikely that the structures can be improved during the synthesis stage. 
Instead, post-separation should be investigated. Horizontal travel under an accelerating 
magnetic field has been successfully applied by other researchers to size-sort magnetic 
nanoparticles and may be useful here.[364]  
Additionally, it is clear that assembly under an in-situ magnetic field is 
preferable to a long one-step synthesis as is presented in chapter 3. Therefore, the amino 
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acid coated iron oxide fibres should be reconsidered in this context. Is it possible, for 
example, to create first a functionalised nanoparticle and then assemble these 
temporarily under a stationary parallel magnetic field, as per the polypyrrole-coated 
material? This would potentially allow more flexibility in terms of the magnetic fibre 
size as it can be live-monitered and controlled.  
Furthermore, some studies on additional methods of synthesising similar 
anisotropic structures bears investigation. In particular, will precipitation of Fe3O4 NPs 
under a strong magnetic result in anisotropic structures?  
2. Exploit photothermal character of Polypyrrole-coated Fe3O4 
A slight photothermal response was recorded in Chapter 4. This should first be 
investigated further. Particularly, the methodology may be improved to fully exclude 
any environmental effects. A fully temperature controlled system (e.g. water bath) 
should be used and the experiment should be scaled up to minimise the error. The 
parameters of material type (e.g. raspberry versus agglomerate), material concentration, 
rotation rate, and wavelength of light used should be explored, decouple and optimised 
before these results are published. It is expected that the heating rate will scale with 
concentration. It would be of interest to confirm that these particular materials absorb in 
the NIR as per literature reports and a similar heating rate should be recorded at these 
wavelengths and compared against visible wavelengths Finally, the effect of having a 
rotating magnetic field in place while the photothermal effect is in action should be 
investigated. It is possible that the heating rate at some distance from the filaments can 
be improved by micro-vortexing as heat transfer is also a diffusion-limited process. 
After this is established, the nanoplatform should be coupled with a heat-sensitive 
component to open another avenue for stimuli-responsive release. A micro-hydrogel 
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bead impregnated with a soluble drug and small enough to sit on the surface of the 
filaments without impeding their rotation is a potential platform.  
3. Patterned release of pharmaceuticals 
Although it appears that the glutamate ions may be ejected from the filaments by 
applying a negative potential, it is important to follow this by attaching a useful moiety 
to the end of the glutamate linker, as per the ketoprofen model drug in other 
experiments in this dissertation. It would also be of impact to show that the release can 
be made directional by controlling the magnetic field.  
4. Polypyrrole-coated Fe3O4 as dynamic platforms for neuron growth 
Related to the above, a growth factor should be attached to the glut-PPy-Fe3O4 
filaments and used for dynamic neuron growth platforms. It is known that neurons will 
grow on growth factor-containing PPy substrates. This is especially enhanced when 
there is current passing through the PPy. The ability to preferentially grow neurons on 
the magnetic filaments with neurite extension along the filament length, followed by the 
ability to move the magnetic platform would be an important achievement.  
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 Appendices 
1. Titration of TiO2 
As-prepared TiO2 NPs and lysine-functionalised TiO2 NPs (prepared in acidic 
conditions) were titrated in order to find their isoelectric points (Figure A1) The 
isoelectric point occurred at 3.5 for as-prepared TiO2.  
 
Figure A1. Titration of TiO2 and lysine-TiO2 NPs to determine their isoelectric points. 
2. Injection of FITC-lys-TiO2 materials into neurons for imaging and excitation 
The FITC-conjugated lysine-functionalised TiO2 NPs created in Chapter 2 were then 
injected into a neuron for imaging to prove that they are compatible with living cells. It 
was found that the optimisation procedure established (using acidic pH, optimising the 
lysine concentration and reaction time) significantly improve the fluorescence of the 
injected particles (Figure A2 b), as expected, compared against the lysine-functionalised 
TiO2 synthesised at non-optimal conditions (Figure A1 a). This significant difference in 
apparent fluorescence of the nanoparticles is attributed to the dual factors of greater 
overall –NH2 content of the optimised structure along with its smaller overall particle 
size that allows for larger surface area for the dye conjugation and greater ability to 
diffuse through the cell.  
i 
 
  
Figure A2. Microscope images of (a) sub-optimal and (b) optimal FITC-lys-TiO2 nanoparticles injected 
in a neuron displaying fluorescence.  
 
3. Calibration curves for Fluorescamine assay of L-glutamic acid and L-
lysine 
The Fluorescamine assay procedure was calibrated for reaction with L-glutamic acid 
and L-lysine standards at various pH. The following curves were produce and used for 
concentration estimates (Figure A3) which were performed at pH 7.6 (green line).   
 
Figure A3. Calibration curves for reaction of Fluorescamine against standard concentrations of (a) L-
glutamic acid and (b) L-lysine at pH 4.65 (red line), pH 7.65 (green line) and pH 8.5 (blue line). 
 
 
 
 
 
a b 
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 4. Magnetic alignment setup 
A schematic of the experimental setup for the magnetically aligned synthesis of 
anistropic Fe3O4 filaments is given below (Figure A4). It was found that a stirring plate 
is required to maintain dispersion of the particles during synthesis.  
 
Figure A4. Schematic experiment setup of magnetically aligned synthesis of anisotropic Fe3O4 filaments.  
 
5. Derivation of nanoparticle motion under an applied magnetic field 
The force on the iron oxide agglomerate can be derived from (S1) considering the 
driving magnetic force (S2) applied at a certain distance from a cylindrical magnet and 
counterbalanced by the drag force (S4).  
𝐹𝐹 =  𝜌𝜌𝜒𝜒?⃑?𝑎 = 𝐹𝐹𝑚𝑚����⃑ + 𝐹𝐹𝑠𝑠���⃑     (S1) 
Where ρ = density of agglomerate; V = volume of the agglomerate.  
Fm is the magnetic force, given as follows:  
 
𝐹𝐹𝑚𝑚 = 𝑉𝑉𝜒𝜒𝜇𝜇 �𝐵𝐵 ∙�����⃑ ∇�𝐵𝐵�⃑     (S2) 
Where μ = permittivity of medium; χ = magnetic susceptibility of the iron oxide.  
The magnetic field, B, for a cylindrical magnet is given:  
 
𝐵𝐵�⃑ = − 𝜇𝜇𝑚𝑚
4𝜋𝜋𝑥𝑥2
      (S3) 
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 Where x = distance from the magnet; m = strength of the magnet.  
The drag force, Fs, is defined as:  
𝐹𝐹𝑠𝑠 =  −6𝜋𝜋𝜋𝜋𝑟𝑟?⃑?𝑣     (S4) 
Where η = dynamic viscosity; r = radius of agglomerate; v = velocity of agglomerate.  
Substituting (S2), (S3), (S4) into (S1), we arrive at (S5) 
𝜌𝜌𝜒𝜒?⃑?𝑎 = 𝜒𝜒𝑉𝑉
𝜇𝜇
�𝐵𝐵�⃑ ∙ ∇�𝐵𝐵�⃑ − 6𝜋𝜋𝜋𝜋𝑟𝑟?⃑?𝑣    (S5) 
Performing the differentiation and approximating agglomerates as perfect spheres of 
radius r yields the following relation.  
𝜌𝜌4𝜋𝜋𝑟𝑟3
3
?⃑?𝑎 = 𝜒𝜒4𝜋𝜋𝑟𝑟3
𝜇𝜇
�
𝜇𝜇2𝑚𝑚2
8𝜋𝜋2𝑥𝑥5
� − 6𝜋𝜋𝜋𝜋𝑟𝑟?⃑?𝑣    (S6) 
This can be rearranged into the following first order differential equation   
?⃑?𝑎 = 𝑑𝑑𝑣𝑣�⃑
𝑑𝑑𝑡𝑡
= −𝑟𝑟𝜒𝜒𝜇𝜇𝑚𝑚2
6𝜋𝜋𝑥𝑥5
−
18𝜂𝜂𝑣𝑣�⃑
4𝑟𝑟2
     (S7) 
This can be solved in the following form 
𝑑𝑑𝑣𝑣
𝑑𝑑𝑡𝑡
+ 𝛽𝛽𝑣𝑣 = 𝛼𝛼      (S8) 
𝑣𝑣 = 𝛼𝛼 + 𝐶𝐶𝑒𝑒−𝛽𝛽𝑡𝑡    (S9) 
Where  
𝛽𝛽 = −18𝜂𝜂
4𝑟𝑟2
     (S10) 
𝛼𝛼 = − 𝑟𝑟𝜒𝜒𝜇𝜇𝑚𝑚2
6𝜋𝜋𝑥𝑥5
     (S11) 
This leads to  
𝑣𝑣 = 𝐶𝐶𝑒𝑒−18𝜂𝜂4𝑟𝑟2𝑡𝑡 + 3𝜒𝜒𝜇𝜇𝑚𝑚2
8𝜋𝜋2𝑥𝑥5𝜌𝜌
     (S12) 
Where C is the integration constant.  
 
Combining (S12) and (1), the collision frequency of agglomerates (2) in the direction of 
the perpendicular applied field may be computed. Note that for r = 100nm, the 
exponential term approaches 0 and may be neglected.  
iv 
 
 𝑣𝑣~ 3𝜒𝜒𝜇𝜇𝑚𝑚2
8𝜋𝜋2𝑥𝑥5𝜌𝜌
      (S13) 
Applying conditions 𝜒𝜒 = 0.1, μ = 710-12 C2N-1m-2, m =1 T , x = 0.01 m, 𝜌𝜌=1000 kg m3 
yields 
𝑣𝑣~ 0.0003 𝑚𝑚/𝑠𝑠    (S14) 
The Peclet number can then be computed for the system:  
𝑃𝑃𝑒𝑒 =  𝑣𝑣𝑟𝑟
𝐷𝐷
     (S15) 
Where D is the diffusion coefficient, given by Stokes-Einstein equation:  
𝐷𝐷 =  𝑘𝑘𝐴𝐴𝑇𝑇
6𝜋𝜋𝜂𝜂𝑟𝑟
     (S16) 
Where kB = Boltzmann constant  
Substituting r = 100nm as a characteristic length scale, Pe ~ 22. Thus, this system is in 
the ballistic regime. Diffusion of the nanoparticles may be neglected. Therefore, the 
final expression for the collision frequency is simply stated as:  
                  𝑍𝑍𝐴𝐴𝐴𝐴 = 4𝑁𝑁𝐴𝐴𝑁𝑁𝐴𝐴𝑟𝑟2𝜋𝜋 �𝐶𝐶𝑒𝑒−18𝜂𝜂4𝑟𝑟2𝑡𝑡 + 3𝜒𝜒𝜇𝜇𝑚𝑚28𝜋𝜋2𝑥𝑥5𝜌𝜌�   (2) 
 
6. Dynamic conductivity of PPy-Fe3O4 filaments at variable magnetic 
rotation speeds 
In Chapter 5, the strong directional dependence of the PPy-Fe3O4 filaments was 
observed in the static situation of a sample of filaments that were allowed to dry on the 
electrode arrays. Some initial experiments on recording the conductivity of the filaments 
while wet under a rotating magnetic field seem to indicate that this directionality can 
also be observed in a dynamic system. The i-t curves (Figure A5) showed a periodic 
behaviour that is consistent with the rotation frequency. Although these results have no 
direct application in this thesis, they have been included in appendices in the hope that 
they will inspire future work on the dynamically tuneable conductivity of PPy-Fe3O4 
filaments.  
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Figure A5. Recorded i-t curves for PPy-Fe3O4 filaments suspended in water with a dynamic rotating 
magnetic field at (a) 0, (b) 60, (c) 120) and (d) 240 rpm.  
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 7. Supplementary Videos V1 and V2 
Video footage showing rotation of the microfilaments (V1) and randomly shaped 
agglomerates (V2) has been included in the attached file.  
In the case of file corruption, the supporting videos can be downloaded at:  
https://www.dropbox.com/s/0dyewlm5uajk8ea/Thesis%20Supplementary%20Videos.zip?dl
=0 
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